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Endings are never easy;
I always build them up so much in my head they can’t possibly live up to
my expectations, and I just end up disappointed.
I’m not even sure why it matters to me so much how things end here. . .
I guess it’s because we all want to believe that what we do is very
important, that people hang onto our every word, that they care what we
think.
The truth is: you should consider yourself lucky if you even occasionally get
to make someone, anyone, feel a little better.
After that it’s all about the people that you let into your life.
And as my mind drifted to faces I’ve seen here before, I was taken to
memories of family, of coworkers, of lost loves, even of those who’ve left us.
And as I rounded that corner, they all came at me in a wave of shared
experience. . .
And even though it felt warm and safe, I knew it had to end.
It’s never good to live in the past too long.
As for the future, thanks to Giusy, it didn’t seem so scary anymore.
It could be whatever I wanted it to be. . .
[Scrubs]
List of publications
(1) D. Collia, M. Vukicevic, V. Meschini, L. Zovatto & G. Pedrizzetti.
Simplified mitral valve modelling for prospective clinical application
of left ventricular fluid dynamics. Journal of Computational Physics,2019,
398:108895. doi:10.1016/j.jcp.2019.108895.
(2) D. Collia, L. Zovatto & G. Pedrizzetti.
Analysis of Mitral Valve Regurgitation by Computational Fluid Dy-
namics left ventricular fluid dynamics. APL Bioengineering, 2019,
3:036105. doi:10.1063/1.5097245. (Editor’s Pick, Featured, Scilight)
(3) C. Celotto, L. Zovatto, D. Collia, & G. Pedrizzetti.
Influence of mitral valve elasticity on flow development in the left ven-
tricle. Eur. J. Mech. B/Fluids, 2019, 75:110-118.
doi:10.1016/j.euromechflu.2018.11.018.
(4) M. Dal Ferro, V. De Paris, D. Collia, D. Stolfo, T. Caiffa, G. Bra-
bati, R. Korcova, B. Pinamonti, L. Zovatto, M. Zecchin, G. Sinagra &
G. Pedrizzetti.
Left Ventricular Response to Cardiac Resynchronization Therapy: In-
sights From Hemodynamic Forces Computed by Speckle Tracking.
Frontiers in Cardiovascular Medicine, 2019, 6:59.
doi: 10.3389/fcvm.2019.00059.
(5) M. Dal Ferro, D. Stolfo, V. De Paris, P. Lesizza, R. korcova, D. Collia,
G. Tonti, G. Sinagra & G. Pedrizzetti.
Cardiac fluid dynamics meets deformation imaging. Cardiovascular
Ultrasound, 2018, 16:4. doi 10.1186/s12947-018-0122-2
i
Abstract
The fluid dynamics in the left ventricle of the human heart is considered
an important marker of long-term cardiovascular outcome. To this end, nu-
merical simulations represent an important tool for integrating the existing
cardiovascular medical imaging modalities and uncover physical flow phe-
nomena. This study presents a computational method for the fluid dynam-
ics inside the left ventricle, designed to be efficiently integrated in clinical
scenarios. It includes an original model of the mitral valve dynamics, which
describes an asymptotic behavior for tissues with no elastic stiffness other
than the constrain of the geometry obtained from medical imaging; in partic-
ular, the model provides an asymptotic description without requiring details
of tissue properties that may not be measurable in vivo. The advantages of
this model with respect to a valveless orifice and its limitations with respect
to a complete tissue modeling are verified. Its performance is then analysed
in detail to ensure correct interpretation of the results. The proposed compu-
tational model represents a potential option when information about tissue
mechanical properties is insufficient for the implementation of a full fluid-
structure interaction approach. Geometries of the left ventricle (LV) and
mitral valve (MV) are extracted from 4D-transesophageal echocardiography.
MV geometries are extracted in open and closed configurations and the intra-
ventricular fluid dynamics pattern is reproduced by a dedicated approach to
direct numerical simulation (DNS) which includes flow-tissue interaction for
the MV leaflet [23]. This approach is applied to both normal and pathologic
ventricles, respectively, to investigate the dynamics of the MV during the
cardiac cycle: how it interacts with the ventricular flow and how it affects
clinical measurements. The dynamics of mitral leaflet opening at the onset of
diastole, as well as closure at the transition between diastole and systole, is
governed by the increased transmitral pressure gradient associated with the
bulk cardiac flow. However, during flow diastasis in the middle of diastolic
filling phase, mitral leaflet motion is primarily influenced by the intraventric-
ular circulation which gives rise to an increased tendency to close the valve
in dilated ventricles. This observation provides a physical interpretation to
echocardiographic measurements commonly employed in the clinical diagnos-
tic process. Our findings demonstrated the properties of false regurgitation,
blood that did not cross the open MV orifice and returns into the atrium
during the systolic retrograde motion of the MV leaflets, whose entity should
be accounted when evaluating small regurgitation [24]. The regurgitating
volume is found to be proportional to the effective orifice area, with the lim-
ited dependence of the LV geometry and type of prolapse. These affect the
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percentage of old blood returning to the atrium which may be associated
with thrombogenic risk. This non-invasive method is useful for the assess-
ment of blood flow, to improve early detection of cardiac dysfunctions and
for provide a concrete helpful in clinical routines.
iii
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1. Introduction
Fluid dynamics is gaining increasing attention in cardiology for the influ-
ence it may have on the long-term outcome of several cardiac dysfunctions
[80, 87]. Numerous studies in literature reported how stresses due to the in-
teraction between flow and tissue play a primary role in the development of
embryonic hearts [4, 25, 55], and flow-mediated forces participate in the pro-
gression or regression of cardiac pathologies in adult hearts [38, 88]. Given
its potential importance, it is foreseeable that measurements of intra-cardiac
fluid dynamics will soon become an integral part of the clinical evaluation
process. Recent advances in cardiovascular imaging permit, to some extent,
measurement of cardiac fluid dynamics in vivo [76, 98]; especially in the
left ventricle (LV), which represents the most energetic and clinically rele-
vant cardiac chamber. However, the imaging technologies able to quantify
blood flow, like Magnetic Resonance Imaging (MRI) and Echocardiography,
present limitations in this respect and applications to clinical practice are
still limited. Direct numerical simulation (DNS) of intraventricular fluid
dynamics represents another possible approach to analyse cardiac flow in in-
dividual patients. DNS can be performed in LV geometries extracted from
clinical images, such as Computed Tomography (CT), MRI or Echocardiog-
raphy, to reproduce the flow under realistic conditions. Recent advances in
DNS of cardiac fluid dynamics were mostly based on the immersed bound-
ary method (IBM). That method was originally introduced from the 1970s
[89, 91, 90], and underwent numerous developments and improvements since
then [30, 71, 72]. In the IBM, the flow equations are resolved in a regular
Cartesian grid with a distribution of fictitious forces concentrated at the im-
mersed solid boundaries whose intensity is matched to ensure fulfilment of
the boundary conditions. IBM is particularly well suited for integration with
medical imaging because the extracted moving geometries are simply im-
mersed inside the fluid domain without the need for specific mesh-generation
procedures. It also allows a relatively straightforward management of closure
and opening of the valves avoiding problems associated with extreme grid
deformation or collapse. Recent reviews outlined the reliability of computa-
tional approaches to analyze LV fluid dynamics [73, 85]. An open challenge
in LV flow simulations is represented by modeling the dynamics of the mitral
valve (MV) that separates the left atrium from the LV and whose dynamics
influences the flow inside the LV. The MV is a bi-leaflet valve with a longer
anterior leaflet side (on the aortic side, separating inflow and outflow tracts)
and a shorter one next to the posterior LV wall. The opening and closure
motion of the asymmetric MV leaflets is mainly driven by the flow with a
minimal elastic resistance from the loose tissue (under normal conditions)
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other than the support of chordae tendineae that avoid retrograde leaflet
displacement and ensure unidirectional flow. In the same vein, the dynam-
ics of the MV leaflets influence vortex formation and the flow that develops
inside the LV during filling phase (diastole), which indirectly affects several
diagnostic markers used in clinical practice as the effective regurgitant orifice
area (EROA), stroke volume (SV), regurgitated volume (Vreg) and more. In
general, the knowledge of the relationship between MV dynamics and LV
flow is very limited because the motion of the valvular leaflets excursion is
too fast for the available time resolution properties of contemporary medi-
cal imaging modalities to allow direct evaluation. The complexity and lack
of reliable in-vivo measurement also make simulations of MV dynamics dif-
ficult; indeed, most numerical studies of LV fluid dynamics are performed
using orifice-like valves, with a fully-open/fully-closed behavior, and do not
include the dynamics of valvular leaflets. Other models of MV dynamics, af-
ter the pioneering numerical studies in the 80’s [91, 90], avoided dealing with
the complexity of a real general fluid-structure interaction (FSI) and consid-
ered a prescribed motion for the leaflets with the main objective of verifying
the differences with valveless orifices [7, 100]. Realistic FSI model are chal-
lenging and are becoming progressively feasible since recently; here, valve
motion obeys the equation for the finite deformation of the elastic material
under the action of a distribution of flow-driven pressure difference between
the two sides of the leaflets [45, 70, 59, 63, 43, 109, 11]. Such a rigorous
approach is best suited for prosthetic valves whose mechanical properties are
known in detail; however, its application in a clinical context may fall short
of the knowledge of the (visco-)elastic properties for the valvular tissues that
are not easily quantifiable in-vivo. Indeed, the mitral leaflets present an inho-
mogeneous structure with variable thickness, made of a non-isotropic fibrous
texture near the annulus which becomes looser and thinner closer to the
leaflet’s free edge [92, 18, 64]. In subject-specific clinical applications elastic
properties are not directly measurable and imaging tools allow extracting the
geometry of the mitral valve with moderate accuracy and limited to a few
instances (typically fully-closed and fully-open configurations, that last some-
what longer). This limited availability of information is commonly overcome
by using average geometric models and parameters that are representative
of a population, an approach that can be appropriate when investigating
properties common to pathological classes. On the other hand, in individ-
ual clinical applications and in the presence of subject-specific pathological
conditions, it is necessary to develop relatively simple models that can best
integrate the few available data for providing information that can be in-
cluded in the clinical process. An asymptotic model for MV dynamics was
previously introduced to reproduce the flow-driven motion of valvular leaflets
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in the absence of elastic resistance [31]. That model was intrinsically limited
to valvular dynamics described by one-degree-of-freedom and was evaluated
in an idealized valvular geometry. The present study, inspired from that
model, introduces an original mathematical framework that permits the as-
sessment of MV dynamics described by an arbitrary number of degrees of
freedom. In principle, the proposed approach may find application to ad-
ditional specialty fields where the motion of structural elements is similarly
driven by fluid flows in the asymptotic limit of negligible elastic or inertial
effects. The internal forces are replaced by an intrinsic stiffness associated
with the description in terms of a limited number of degrees of freedom. In
the present application, this approach is integrated with imaging technology
for the numerical solution of MV leaflets motion with geometry effectively
obtained from individual recordings. Mitral valve prolapse (MVP) due to
myxomatous leaflet degeneration is the most prevalent cause of the mitral
regurgitation (MR) [78, 36]. To-date several markers are used routinely in
clinical practice for the integrated evaluation of MR severity, including quali-
tative (i.e., colour flow jet area, flow convergence), semi-quantitative Doppler
(i.e., vena contracta width) and quantitative Doppler (effective regurgitant
orifice area, regurgitant volume and fraction) parameters [110]. The vena
contracta method [105, 46] estimates the size of the regurgitant orifice by
measuring the minimum diameter of the regurgitant flow jet distal to (or
at) the plane of the anatomic regurgitant orifice; and while this direct rela-
tionship is relatively independent of flow rate and pressure gradient in less
dynamic orifice areas (as in holosystolic MR), measurement errors may lead
to overestimation when MR is limited to mid or late systole, or is biphasic
(i.e., secondary MR) or transient (secondary MR, ventricular ectopy or de-
lay). The Proximal Isosurface Velocity Area (PISA) method may overcome
this limitation by evaluating the regurgitant volume instead, based on the 2D
color-Doppler signal of the converging flow proximal to the anatomic orifice.
The flow velocity is shown with different colors, and the assumption of hemi-
spheric converging flow allows estimating the flow rate based on the value of
one isovelocity contour. This method is the most utilized for its simplicity,
but remains prone to error because the PISA area is not always hemispheric
when the regurgitant orifice is non cicrcular,often, as with functional MR
which may exhibit a crescent or elliptical shape; moreover, PISA calculation
relies on instantaneous measures that are averaged to the cardiac cycle for
a volumetric estimation (typically assuming a proportion with the velocity
trace measured with Doppler at the LV outflow) [96]. In recent years, the
increasing spread of 3D echocardiography and cardiac magnetic resonance
(CMR) allows more accurate evaluations of MR. High quality phase-contrast
CMR with velocity-encoded imaging is used for estimating the aortic flow
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and calculates the absolute regurgitant volume from the volume rate differ-
ence in the left ventricle (LV). This approach is considered the most reliable
although it calculates MR from a difference, rather than directly on the mi-
tral valve (MV), presenting some degree of variability [76]. The effective
orifice area (EOA) [35, 53, 57] represents a more anatomic marker of MR
severity; this approach also presents various limitations partly imputable to
the difficulty of measuring the EOA directly from images of the MV orifice
(MVO). Although these methods provide surrogate markers for MR severity
in the routine clinical environment, the description of the flow phenomena
involved in MR remains unclear, further compounded by the wide variability
in loading conditions, timing of MR and pathoanatomic stigmata of disease
seen with different MR etiologies, indirectly impacting the flow dynamics
associated with the MV despite similar degrees of MR severity and compa-
rable EROA sizes. Through this study is possible to get deeper insight into
the flow phenomena associated with MR. This is achieved by reproducing,
using direct numerical simulation (DNS), the fluid dynamics in the LV in
correspondence with pathologic MVPs obtained from clinical images. This
approach allows estimating the cardiac fluid dynamics associated with dif-
ferent types and gravity of MVPs and how the actual regurgitant volume is
correlated with EOA. The primary objective of this non-invasive method is
to provide a novel, sensitive and reproducible marker of subtle, subclinical
myocardial dysfunction particularly in asymptomatic patients without class-
I indications of surgical intervention, that is, prior to the advent of overt LV
remodeling in the presence of moderate to severe MR through the assessment
of blood flow dynamics.
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2. The cardiovascular system
The cardiovascular system is composed of: heart, blood vessels (also
known as the vasculature), cells and plasma of the blood. Blood vessels
that carry blood away from the heart are called arteries. Blood vessels that
return blood to the heart are called veins. As blood moves through the car-
diovascular system, a system of valves in the heart and veins ensures that
the blood flows in one direction only. Figure 1 is a schematic diagram that
shows these components and the route that blood follows through the body.
The heart is divided by a central wall, or septum, into left and right halves.
Each half functions as an independent pump that consists of an atrium and
a ventricle. The atrium receives blood returning to the heart from the blood
vessels, and the ventricle pumps blood out into the blood vessels. The right
side of the heart receives blood from the tissues and sends it to the lungs for
oxygenation. The left side of the heart receives newly oxygenated blood from
the lungs and pumps it to tissues throughout the body. Starting in the right
atrium in Figure 1, trace the path taken by blood as it flows through the car-
diovascular system. Note that blood in the right side of the heart is colored
blue. This is a convention used to show blood from which the tissues have
extracted oxygen. Although this blood is often described as deoxygenated, it
is not completely devoid of oxygen. It simply has less oxygen than blood go-
ing from the lungs to the tissues. From the right atrium, blood flows into the
right ventricle of the heart. From there it is pumped through the pulmonary
arteries to the lungs, where it is oxygenated. Note the color change from blue
to red in Figure 1, indicating higher oxygen content after the blood leaves the
lungs. From the lungs, blood travels to the left side of the heart through the
pulmonary veins. The blood vessels that go from the right ventricle to the
lungs and back to the left atrium are known collectively as the pulmonary
circulation. Blood from the lungs enters the heart at the left atrium and
passes into the left ventricle from mitral valve. Blood pumped out of the
left ventricle enters the large artery known as the aorta. The aorta branches
into a series of smaller and smaller arteries that finally lead into networks of
capillaries. Notice at the top of Figure 1 the color change from red to blue
as the blood passes through the capillaries, indicating that oxygen has left
the blood and diffused into the tissues.
After leaving the capillaries, blood flows into the venous side of the circu-
lation, moving from small veins into larger and larger veins. The veins from
the upper part of the body join to form the superior vena cava. Those from
the lower part of the body form the inferior vena cava. The two venae cavae
empty into the right atrium. The blood vessels that carry blood from the
left side of the heart to the tissues and back to the right side of the heart are
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Figure 1: Blood flow in the human heart
collectively known as the systemic circulation.
2.1. Cardiac muscle of the heart
The heart is a muscular organ, about the size of a fist. It lies in the
center of the thoracic cavity. Within the thoracic cavity, the heart lies on
the ventral side, sandwiched between the two lungs, with its apex resting
on the diaphragm. The heart is encased in a tough membranous sac, the
pericardium. A thin layer of clear pericardial fluid inside the pericardium
lubricates the external surface of the heart as it beats within the sac. The
heart itself is composed mostly of cardiac muscle, or myocardium, covered
by thin outer and inner layers of epithelium and connective tissue. The
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major blood vessels all emerge from the base of the heart. The aorta and
pulmonary trunk (artery) direct blood from the heart to the tissues and
lungs, respectively. The venae cavae and pulmonary veins return blood to
the heart. Blood flows from veins into the atria and from there through one-
way valves into the ventricles, the pumping chambers. Blood leaves the heart
via the pulmonary trunk from the right ventricle and via the aorta from the
left ventricle. A second set of valves guards the exits of the ventricles so that
blood cannot flow back into the heart once it has been ejected.
Figure 2: Structure of the heart
Notice in Figure 2 that blood enters each ventricle at the top of the
chamber but also leaves at the top. This is because during development, the
tubular embryonic heart twists back on itself. This twisting puts the arteries
(through which blood leaves) close to the top of the ventricles. Function-
ally, this means that the ventricles must contract from the bottom up so
that blood is squeezed out of the top. Four fibrous connective tissue rings
surround the four heart valves (Figure 2). These rings form both the origin
and insertion for the cardiac muscle, an arrangement that pulls the apex
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and base of the heart together when the ventricles contract. In addition,
the fibrous connective tissue acts as an electrical insulator, blocking most
transmission of electrical signals between the atria and the ventricles. This
arrangement ensures that the electrical signals can be directed through a
specialized conduction system to the apex of the heart for the bottom-to-top
contraction.
Figure 3: The heart conduction system
The bulk of the heart is composed of cardiac muscle cells, or myocardium.
Most cardiac muscle is contractile, but about 1% of the myocardial cells are
specialized to generate action potentials spontaneously. These cells account
for a unique property of the heart: its ability to contract without any outside
signal. The signal for myocardial contraction comes from specialized myocar-
dial cells known as autorhythmic cells. The autorhythmic cells are also called
pacemakers because they set the rate of the heartbeat. Electrical communi-
cation in the heart begins with an action potential in an autorhythmic cell.
The depolarization spreads rapidly to adjacent cells through gap junctions
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in the intercalated disks. The depolarization wave is followed by a wave
of contraction that passes across the atria, then moves into the ventricles.
The depolarization begins in the sinoatrial node (SA node), autorhythmic
cells in the right atrium that serve as the main pacemaker of the heart (Fig-
ure 3). The depolarization wave then spreads rapidly through a specialized
conducting system of noncontractile autorhythmic fibers. A branched intern-
odal pathway connects the SA node to the atrioventricular node (AV node),
a group of autorhythmic cells near the floor of the right atrium. From the
AV node, the depolarization moves into the ventricles. Purkinje fibers, spe-
cialized conducting cells, transmit electrical signals very rapidly down the
atrioventricular bundle (AV bundle, also called the bundle of His) in the ven-
tricular septum. A short way down the septum, the AV bundle fibers divide
into left and right bundle branches. The bundle branch fibers continue down-
ward to the apex of the heart, where they divide into smaller Purkinje fibers
that spread outward among the contractile cells. The heart conduction can
be registrated by electrocardiogram (ECG) and a typical trace is reported
in figure 4. The QRS complex in the ECG indicates the polarization of the
ventricular myocardial fibers, after which the ventricular contraction devel-
ops. The ventricular contraction, or systole, pushes blood in the circulation.
When contraction is completed the muscular fibers depolarize, revealed by
the T-wave in the ECG, and relax allowing the blood to fill the ventricle dur-
ing diastole. Diastole is then completed by the following atrial contraction.
The heart conduction system have a parallel mechanical cycle of ventrivular
filling and ejection.
With reference to figure 4 during systole the LV contracts, the mitral
valve is closed, its volume decreases and flow is ejected (S-wave) at systolic
pressure through the Aorta, during the early filling the myocardium relaxes,
pressure decreases below that of the left atrium, aortic valve closes, mitral
valve opens and blood flows into the LV that increases its volume; when the E-
wave terminates the atrial and ventricular pressure become comparable and
flow into the ventricle is very small during diastasis. The atrial contraction
completes with the LV filling (A-wave) and the diastolic phase.
2.2. The cardiac cycle
Each cardiac cycle has two phases: diastole, the time during which car-
diac muscle relaxes, and systole, the time during which the muscle contracts
diastole, dilation; systole, contraction. Because the atria and ventricles do
not contract and relax at the same time, we discuss atrial and ventricular
events separately. The flow of blood through the heart is governed by the
same principle that governs the flow of all liquids and gases: flow proceeds
from areas of higher pressure to areas of lower pressure. When the heart
9
Figure 4: The electro-mechanical cycle
contracts, the pressure increases and blood flows out of the heart into areas
of lower pressure. Figure 5 represents pressure and volume changes in the
left ventricle, which sends blood into the systemic circulation. The left side
of the heart creates higher pressures than the right side, which sends blood
through the shorter pulmonary circuit.
The cycle begins at point A. The ventricle has completed a contraction
and contains the minimum amount of blood that it will hold during the cycle.
It has relaxed, and its pressure is also at its minimum value. Blood is flow-
ing into the atrium from the pulmonary veins. Once pressure in the atrium
exceeds pressure in the ventricle, the mitral valve between the atrium and
ventricle opens (Figure 5, point A). Atrial blood now flows into the ventricle,
increasing its volume (point A to point B). As blood flows in, the relaxing
ventricle expands to accommodate the entering blood. Consequently, the
volume of the ventricle increases, but the pressure in the ventricle goes up
very little. The last portion of ventricular filling is completed by atrial con-
traction (point A’ to B). The ventricle now contains the maximum volume of
blood that it will hold during this cardiac cycle (point B). Because maximum
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Figure 5: LV Pressure-Volume curve [2013, Person Education, Inc.]
filling occurs at the end of ventricular relaxation (diastole), this volume is
called the end-diastolic volume (EDV). When ventricular contraction begins,
the mitral valve closes. With both the AV valve and the semilunar valve
closed, blood in the ventricle has nowhere to go. Nevertheless, the ventri-
cle continues to contract, causing the pressure in this chamber to increase
rapidly during isovolumic contraction (B −→ C in Figure 5). Once ventric-
ular pressure exceeds the pressure in the aorta, the aortic valve opens (point
C). Pressure continues to increase as the ventricle contracts further, but ven-
tricular volume decreases as blood is pushed out into the aorta (C −→ D).
The heart does not empty itself completely of blood each time the ventricle
contracts. The amount of blood left in the ventricle at the end of contrac-
tion is known as the end−systolic volume (ESV). The ESV (point D) is the
minimum amount of blood the ventricle contains during one cycle. At the
end of each ventricular contraction, the ventricle begins to relax. As it does
so, ventricular pressure decreases. Once pressure in the ventricle falls below
aortic pressure, the semilunar valve closes, and the ventricle again becomes
a sealed chamber. The remainder of relaxation occurs without a change
in blood volume, and so this phase is called isovolumic relaxation (Figure
5, D −→ A). When ventricular pressure finally falls to the point at which
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atrial pressure exceeds ventricular pressure, the mitral valve opens and the
cycle begins again. Cardiac output (CO) can be calculated by multiplying
heart rate (beats per minute, bpm) by stroke volume (mL per beat, or per
contraction):
Cardiac output = Heart rate× Stroke volume (1)
A physiological value of CO is about 5 L/min. For instance, for an average
resting heart rate of 72 beats per minute and a stroke volume of 70 mL per
beat, we have 5 L/min. Average total blood volume is about 5 liters. This
means that, at rest, one side of the heart pumps all the blood in the body
through it in only one minute. Normally, cardiac output is the same for both
ventricles. However, if one side of the heart begins to fail for some reason and
is unable to pump efficiently, cardiac output becomes mismatched. In that
situation, blood pools in the circulation behind the weaker side of the heart.
Stroke volume, the volume of blood pumped per ventricle per contraction,
is directly related to the force generated by cardiac muscle during a con-
traction. Normally, as contraction force increases, stroke volume increases.
In the isolated heart, the force of ventricular contraction is affected by two
parameters: the length of muscle fibers at the beginning of contraction and
the contractility of the heart. The volume of blood in the ventricle at the
beginning of contraction (the end-diastolic volume) determines the length of
the muscle. The length-tension relationship observed in isolated muscles can
also be seen in the intact heart: as stretch of the ventricular wall increases,
so does the stroke volume. If additional blood flows into the ventricles, the
muscle fibers stretch, then contract more forcefully, ejecting more blood. The
degree of myocardial stretch before contraction begins is called the preload on
the heart because this stretch represents the load placed on cardiac muscles
before they contract. The stroke volume is calculated as SV=EDV-ESV and
it’s usually normalized with the EDV to provide a dimensionless measure of
the entity of the contraction relative to the available volume. This measure
is defined ejection fraction
EF =
VED − VES
VED
=
SV
VED
(2)
which represents the most common clinical parameter to assess the LV func-
tion. Evaluation of EF requires the evaluation of LV volumes, which can be
performed with numerous methods based on imaging, from echocardiogra-
phy to MRI and others. In normal hearts the EF is usually about 65%, and
considered abnormal when it falls below 55% (although exact figures depend
on the measurement method). The reduction of the EF commonly reveal the
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presence of a cardiac dysfunction, although there are also few pathologies
that present a preserved EF.
Figure 6: Starling curve
The relationship between stretch and force in the intact heart is plotted
on a Starling curve (Figure 6). The x-axis represents the end-diastolic vol-
ume. This volume is a measure of stretch in the ventricles, which in turn
determines sarcomere length. The y-axis of the Starling curve represents the
stroke volume and is an indicator of the force of contraction. The graph
shows that stroke volume is proportional to EDV. As additional blood enters
the heart, the heart contracts more forcefully and ejects more blood. This
relationship is known as the Frank-Starling law of the heart. It means that
within physiological limits, the heart pumps all the blood that returns to it.
According to the Frank-Starling law, stroke volume increases as end-diastolic
volume increases. End-diastolic volume is normally determined by venous re-
turn, the amount of blood that enters the heart from the venous circulation.
Three factors affect venous return: (1) contraction or compression of veins re-
turning blood to the heart (the skeletal muscle pump); (2) pressure changes
in the abdomen and thorax during breathing (the respiratory pump); (3)
sympathetic innervation of veins. The combined load of EDV and arterial
resistance during ventricular contraction is known as afterload. Increased
afterload is found in several pathological situations, including elevated arte-
rial blood pressure and loss of stretchability (compliance) in the aorta. To
maintain constant stroke volume when afterload increases, the ventricle must
increase its force of contraction, which then increases the muscle’s need for
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oxygen and ATP production. If increased afterload becomes a chronic sit-
uation, the myocardial cells hypertrophy, resulting in increased thickness of
the ventricular wall. Clinically, arterial blood pressure is often used as an
indirect indicator of afterload. Cardiac output varies with both heart rate
and stroke volume. Heart rate is modulated by the autonomic division of the
nervous system and by epinephrine.
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3. Left ventricular disease
Pathologies of the left ventricle can be roughly classified, by a mechani-
cal viewpoint, as those due to a reduced myocardial contraction (perfusion
defect) or to a general inability to properly deliver an appropriate contrac-
tion/relaxation rhythm that can progressively lead to the syndrome of heart
failure. Further pathologies are imputable to dysfunctions of electrical con-
duction; some of these can be purely neurological defects, like fibrillations,
some others can lead to improper contraction or relaxation and, either me-
chanically or therapeutically, are included in the class of heart failure. Other
dysfunctions are imputable to pathologies of cardiac valves, which are dis-
cussed later in dedicated sections. It should altogether keep in mind that
many such pathologies are inter-related and the present classification is driven
by discussion on intraventricular fluid dynamics more than on clinical sce-
narios.
3.1. Myocardial ischemia
The most known pathology of the left ventricle is ischemia, whose extreme
is the myocardial infarction, that is a consequence of the reduction of my-
ocardial perfusion due to coronary stenosis. This is, therefore, a consequence
of vascular disease; when a coronary reduces blood flow, the myocardial ter-
ritory perfused by that vessel receives less oxygen allowance and reduces its
contractile ability. The ischemic disease is commonly considered a systolic
dysfunction because the myocardium is unable to properly contract during
systole. Ischemic diseases present a reduction of the EF; this reduction is
mostly due to regional contractile defect, in the poorly perfused myocardial
region, that can be recognized by cardiac imaging methods allowing visual-
ization and quantification of myocardial motion. When this defect is small,
it can be hidden and may become appreciable only under stress condition,
thus requiring imaging performed under exercise of pharmacologic stress. In
alternative, perfusion defects can be evaluated by perfusion imaging tech-
niques, available in nuclear imaging, MRI and, sometime, echocardiography.
When recognized, they are eventually evaluated by coronary angiography to
assess the actual coronary stenosis as discussed previously. Intraventricular
fluid dynamics is also affected by myocardial ischemia. Blood near a seg-
ment that presents a reduced motility is more stagnant, especially when this
is near the LV apex. This gives a reduction of wash-out and increased risk of
thrombi. It also creates an imbalance in the intraventricular forces with over-
stresses in some regions, even distant from the infarcted zone. Over-stresses,
or anomalous stresses, can progressively induce a feedback and ventricular
adaptation that alters the LV geometry with potential further pathological
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implications. Ischemia is typically solved by coronary endovascular surgery.
However, when the solution is not complete, for example when one or few
are treated among multiple stenosis, some ischemia may remain and give
ventricular imbalances. Similarly, when the ischemia has lasted for too long
time, some regions of the myocardium may not be able to fully recover its
contractile ability. In presence of such remaining imbalances may induce
ventricular adaptation and progressive dysfunction.
3.2. Heart failure
Heart failure (HF) is the principal social threatening cardiac progres-
sive dysfunction. It presents either as a primary pathology or as a conse-
quence of numerous primary diseases. It can be a consequence of partly
recovered ischemia; it can follow electrical dysfunctions that do not allow a
synchronous of contraction; it can simply due to varied stiffness/thickness
in the myocardium that does not allow a uniform relaxation, to cite a few
examples. On the other hand, it can develop as a primary disease following
poor medical conditions. In any case, heart failure is the terminal stage of
a progressive disease associated with impaired cardiac function. The clinical
syndrome of heart failure is associated with the development of ventricular
remodeling: a modification of ventricular geometry that progressively alters
its functional parameters whose final stage is the LV dilatation, known as
dilated cardiomyopathy (DCM). Remodeling represents a physiologic adap-
tation feedback that often does not lead to a stable configuration rather to
a progressively worsening of the cardiac function and eventually to failure.
Despite modern treatments, hospitalization and death rate remains high,
with nearly 50% of people diagnosed with heart failure dying within 5 years.
The physiological causes leading to LV remodeling (as exemplarily sketched
Figure 7: Progression of left ventricular (LV) remodelling after an ischemic event. Left
side: a ventricle with normal geometry and a regional reduced contractility. Centre: a
moderately dilated ventricle. Right: a dilated cardiomyopathy at the late stage of heart
failure.
in Figure 7 for a case of ischemia) are mainly ascribed to an increase of
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stress on the myocardial fibers, which stimulates the growth and multiplica-
tion of cells giving rise to an increase of muscular thickness (hypertrophy) or
extension (local dilatation). However this picture is unable to differentiate
patients exhibiting differences in LV structure and function, it is not consis-
tently predictive of the future risk of cardiac remodeling and does not clarify
how a regional disease rapidly remodels the LV as whole. The availability of
predictive models that can forecast progression or reversal of LV remodeling
following initiation of therapeutic interventions would be invaluable for over-
all risk stratification, improvement of preventive healthcare, and reduction
of the perspective social burden. Progressive disease and heart failure have
Figure 8: Types of remodeling and heart failure.
numerous possible causes and can also develop in different ways, as shown
in figure 8. Heart failure is most commonly associated to ventricular dilata-
tion (DCM). In this case, the myocardium is stretched and thinner. The
heart muscle contract very little and is able to eject a sufficient SV with
small contraction because of the large volume. The EF is well reduced, and
we talk about HF with reduced ejection fraction (HFrEF), also referred to
as systolic heart failure. In HFrEF, the intraventricular fluid dynamics is
very weak; the SV is a small percentage of the chamber volume. Typically,
blood flow takes either a continuous weak rotary motion, when the inflow
is aligned to feed the central vortex, or it presents a weak turbulence. In
both cases, flow is featured by stasis and thrombus risk. Intraventricular
hemodynamic forces are reduced and incoherent. Another type of HF is
associated with thickening and/or stiffening of the myocardium. The ven-
tricular volume is about normal and the pumping parameters are also normal
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but the ventricle does not relax properly during ventricular filling because
of its stiffness. The EF is thus preserved, usually because the ventricle is
hypertrophic and the inward thickening helps supporting systolic ejection.
volume reduction. In this case, that is more difficult to recognize, we talk
about HF with preserved ejection fraction (HFpEF), also referred to as di-
astolic heart failure. Intraventricular blood flow in this case is more similar
to normal; however, dynamical difference reflecting the altered filling pattern
are expected although not studied, yet. The causes leading to LV remodeling
are still largely incomplete. During the progression there are changes in the
pumping function. These can be noticed by changes in the relative intensity
between E-wave and A-wave, with an extra-burst by atrial contraction when
early filling is insufficient, or alteration of timing of acceleration and decays
of E-wave. Clinicians use the combination of numerous indicators trying to
figure out the specific pathological scenario; however a comprehensive me-
chanical picture is still missing. It has been recently shown that alteration in
the intraventricular fluid dynamics are observable well before the tissue has
undergone to noticeable often-irreversible changes. Given the incompress-
ible nature of blood, in a cardiac chamber that is filled with blood, every
segment is somehow in touch with the others and, as a result, the blood
inertia associated with the rapid acceleration-deceleration about one region
can instantaneously influence distant regions. The role of flow on cardiac re-
modeling has been considered in the past only through global indicators like
volumetric changes, the inflow velocity of E- and A-wave, or combinations
thereof. The absence of more specific fluid dynamics indicators is mainly due
to the lack of technologies able to evaluate intraventricular fluid dynamics
with sufficient ease and reliability. Normal intraventricular fluid dynamics
is known to be associated to a physiologically stable cardiac function that
does not lead to remodeling. Vice versa, a progressive disease corresponds
to a physiologically unstable state that is expected to proceed further away
from normality. As shown schematically in figure 9, an alteration of intra-
ventricular fluid dynamics induces alteration of forces and shear stress on
the tissue, these can trigger adaptation feedbacks and bring to progressive
dysfunction. In an initial phase, the alteration of flow-mediated stresses may
lead to stiffening of the myocardial tissue that sometime is associated to the
increase of myocardial thickness (hypertrophy). This can be a condition go-
ing to HFpEF, or a quick passage toward progressive tissue dilatation with
further reduction of LV function and eventually going to the more common
HFrEF. Therapies for heart failure are complicated as they should go to
the cause leading to remodeling. Moreover, HF often involves dysfunction
in physiologically related organs and, therefore, precise guidelines are not
available, and therapies are varied. Multipoint pace makers were shown to
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Figure 9: Flow-mediated path toward heart failure.
be one successful option in many cases, especially when HF is associated
with a disturbed electrical activity (either as a cause or a consequence of
HF), because they permit to restore a synchrony in LV contraction and re-
laxation. This approach, called cardiac resynchronization therapy (CRT),
requires the definition of stimulation intervals in the pace-maker to ensure
optimal therapeutic outcome. Typically, they can be chosen by electric con-
duction optimization or though synchronization of myocardial tissue motion.
However, the rate of success is still low (nearly 40% patients do not bene-
fit of CRT). Fluid dynamics offers a global perspective to define the proper
contraction pattern, by ensuring that hemodynamic forces are maximized
and properly aligned along the base-apex direction. However, studies are
currently in progress to verify its effective clinical results. This concept can,
however, be generalized to evaluate the normality of cardiac function after
the acute cause that may, or may not, lead to heart failure. These include
endovascular prosthesis, valvular repair or transplant, and so on. Intraven-
tricular fluid dynamics appears as the first mechanical factor modified after,
even minor, alteration of cardiac function. It appears a promising central
element for the prediction of progressive disease or of therapeutic outcomes.
19
4. Mitral valve anatomy and disease
4.1. Mitral valve anatomy
The mitral valve is a bi-leaflet structure composed by annulus, commis-
sures, leaflets, chordae tendineae and papillary muscles, and left ventricle is
crucial for its functional integrity (figure 10). The mitral annulus is a fibro-
Figure 10: Mitral valve, close (left) and open (right) showing the chordae tendineae at-
taching the leaflets to the papillary muscles inside the ventricle
muscular ring to which the anterior and posterior mitral valve leaflets attach.
The right trigone is a fibrous area situated between the membranous septum,
the mitral valve, the tricuspid valve, and the noncoronary cusp at the aortic
annulus. The left trigone is a fibrous area located at the nadir of the left
coronary cusp of the aortic annulus and the left border of the aortic-mitral
curtain. The aortic-mitral curtain is the fibrous tissue between the anterior
mitral valve leaflet, the left and noncoronary cusps of the aortic valve, and
the left and right trigone [10]. The posterior portion of the annulus is less
developed owing to the discontinuity of the fibrous skeleton of the heart in
this region. This difference explains why the posterior portion of the mitral
annulus is more prone to pathologic dilation while the anterior portion is
relatively resistant [62]. The annulus is a dynamic non-planar structure that
undergoes deformation in its circumference, excursion, curvature, shape, and
size for proper function, which makes it susceptible to ventricular remodeling
[66, 49]. The atrial surface is free of any attachments whereas the ventricu-
lar surface connects to the papillary muscles via the chordae tendinae. The
chordae tendinae are fibrous extensions originating from the heads of the pap-
illary muscles and are responsible for determining the position and tension
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on the anterior and posterior leaflets at LV end-systole. The two papillary
muscles, the anterolateral and the posteromedial, originate from the area be-
tween the apical and middle thirds of the LV free wall. The anterior leaflet
is the largest, positioned between the mitral orifice and the left ventricular
outflow tract, while the smaller posterior leaflet is placed to the left of the
mitral orifice close to the posterior-lateral wall.
Figure 11: Schematic diagram of the mitral valve
Functional classification of valve dysfunction, is based Carpentier’s [15]
characterization of leaflet motion that identifies the anterolateral, medial
and posteromedial scallops of the posterior leaflet as P1, P2 and P3, and the
anterior leaflet as A1, A2 and A3, respectively [24]. The distinct area where
the anterior and posterior leaflets coapt during systole is known as the rough
zone.
4.2. Mitral valve prolapse
Mitral valve prolapse (MVP) is the common cause of the mitral regurgi-
tation (MR) that affects approximately 2.4% of the population [41], which
is typically caused by myxomatous degeneration of the valve [34]. Func-
tional classification of MR is based Carpentier’s pathophysiologic triad [15],
it classifies MV dysfunction based on three types of leaflet motion. In type
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I the leaflets have a normal movement and regurgitation is due to annular
dilatation and incomplete coaptation of the leaflets from insufficient available
surface of coaptation; in type II the leaflets are prolapsed or hypermobile, due
to excess leaflet height, volume, elongation or rupture of chordae tendineae
or by lengthening or rupture of the papillary muscles. Finally, in type III
dysfunction the leaflets have a restricted movement caused by chordal tether-
ing from chordal fibrosis, papillary displacement, and/or leaflet fibrocalcific
or hypoplastic etiology. MVP results primarily from two distinctive types of
degenerative disease: Barlow’s disease and fibroelastic deficiency.
4.2.1. Barlow’s disease
Barlow disease results from an excess of myxomatous tissue, which is an
abnormal accumulation of mucopolysaccharides in one or both leaflets and
chordae [5]. This myxoid infiltration results in thick, redundant, billowing
leaflets and elongated chordae, which often lead to bileaflet, multisegmental
prolapse (Figure 12 (a))and is seen often in younger patients.
Figure 12: Pathological MV: (a) Barlow disease, (b) Fibroelastic deficiency.
4.2.2. Fibroelastic deficiency
Fibroelastic deficiency results in acute loss of mechanical integrity due
to abnormalities in the connective and elastic fibrous elements of the leaflet
extracellular matrix scaffold architecture [5]. It usually leads to either a lo-
calized or unisegmental prolapse due to chordal elongation or rupture (Figure
12 (b)). Fibroelastic deficiency is more prevalent in older patients over 65.
4.3. Ischemic mitral regurgitation
Ischemic MR is a pathophysiologic outcome of ventricular remodeling
arising from ischemic heart disease. The adverse changes that occur in the
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ventricle after an ischemic event commonly result in type IIIB dysfunction
of the mitral valve with leaflet restriction during systole [15]. The resultant
volume overload caused by MR worsens myocardial contractility, which in
turn worsens LV dysfunction, eventually leading to heart failure and death
[61, 48].
4.4. Mitral stenosis
The most prevalent cause of native mitral stenosis (MS) is rheumatic mi-
tral valve disease [102], other causes including congenital, inflammatory, and
infiltrative etiologies. These diseases result in lesions such as commissure
fusion (in rheumatic disease), leaflet thickening and retraction, and chordae
fusion, which lead to leaflet restriction primarily during diastole [56]. Accord-
ing to Carpentier’s classification of mitral valve dysfunction, this constitutes
a type IIIA dysfunction [15].
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5. Mitral valve surgical approach
5.1. Mitral valve repair
Degenerative mitral valve disease is defined by a wide spectrum of lesions
and therefore requires a wide variety of surgical techniques to be repaired [1].
Mitral valve repair is performed following a sequential approach as follows:
(1) Repair of all areas of valve pathology;
(2) Reestablishment of leaflet support and surface of coaptation;
(3) Creation of a posterior leaflet closure line away from the outflow tract;
(4) Stabilization of the repair with an annuloplasty device;
(5) Repair of any residual lesions following primary repair.
If posterior leaflet prolapse is due to fibroelastic disease, it is most com-
monly treated by a targeted triangular (Figure 13 (a)) resection of the seg-
ment affected [2]. The prolapsing segment is subsequently removed, and
primary closure of the resection margins restores leaflet continuity. In the
setting of limited leaflet tissue, a more conservative approach is preferred
to avoid undue leaflet tension. Non resection strategies may involve leaflet
resuspension and/or ventricular using using artificial chordae from expanded
polytetrafluoroethylene (ePTFE) (loop technique, loop-in-loop technique, or
single neochordoplasty) (Figure 13 (c)). If additional coaptation surface is
required, free edge remodeling strategies may be used including division of
primary and secondary restrictive chordae and mobilization of the remain-
ing leaflet body and tethered clefts. In the presence of diffuse excess leaflet
height and/or width a sliding leaflet- plasty may be used to correct the resid-
ual height (Figure 13 (b)). Reattachment of the leaflet to the annulus will
reduce the leaflet height several millimeters, depending on the depth of suture
bites. Any gaps in support, or any areas supported by thinned-out chordae
(even in the absence of prolapse), are reinforced by transposition of previ-
ously detached secondary chordae, or artificial PTFE neochords. Correction
of residual anterior leaflet dysfunction is usually addressed after the insertion
of the annuloplasty device. The anatomic disposition of the anterior leaflet
does not allow aggressive resection of the leaflet margins. Therefore, surgical
strategy to correct opposing anterior leaflet prolapse includes targeted (lim-
ited to the rough area of the leaflet) or no resection. After saline testing with
pressurization of the left ventricle, correction of the anterior leaflet prolapse
using one or a combination of the following techniques might be performed:
(1) Chordal transfer of healthy secondary chordeae, or posterior leaflet flip,
using a small segment of posterior leaflet free edge with its attached
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Figure 13: Different surgical approaches of MV reparation. (a) Triangular resection, (b)
quadrangular resection and sliding leaflet plasty, (c) neochordoplasty with polytetrafluo-
roethylene sutures [16].
native chordae;
(2) Neochordoplasty with artificial PTFE chordae;
(3) Limited triangular resection of a prolapsing segment.
Finally, commissural prolapse can be addressed by placing one or two ver-
tical mattress sutures to imbricate the opposing segments of A1/P1 or A3/P3
segments. PTFE neochords may be used to support the reconstructed com-
missure as needed [16]. The mitral annulus is also examined to assess the
presence of annular dilation, which is very common in advanced mucoid de-
generation, and should always be considered prior to committing to resection
strategies as well as to assess the risk of systolic anterior motion of the an-
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terior leaflet and/or chordae [14] (Figure 14). Because leaflet restriction in
ischemic MR results in less leaflet tissue available for coaptation, it is neces-
sary to use a complete remodeling ring [42] to ensure an adequate surface of
coaptation after annuloplasty [26]. This method combines the principles of
undersizing with the specific asymmetric deformation observed with type IIIb
ischemic MR. In cases of severe leaflet tethering and moderate to severe LV
dilation, several adjunctive techniques as well as alternative procedures have
been advocated, including division of secondary chords, [13] posterior leaflet
extension with a pericardial patch, repositioning of the papillary muscles,
and mitral valve replacement with chordal sparing [12].
Figure 14: Ischemic mitral regurgitation repair. (a) typical findings with leaflet restriction
predominantly in the P2-P3 region, (b) sizing of the annulus with a ring sizer, (c) the
sutures in the annulus at the position of the anterior commissure and trigone are placed
last, taking advantage of previously placed sutures to expose this area, (d) after placement
of a full-remodeling ring, the surface of coaptation is restored (below the plane of the
annulus) [16].
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5.2. NeoChord procedure
The NeoChord procedure is a feasible alternative to conventional surgery
for patients in the early stages of disease, when the lesions responsible for the
mechanism of mitral regurgitation are limited to the mitral leaflets and/or
chordae tendinae, including elongation or rupture, and do not include mi-
tral annular or LV cavity dilatation [22]. This procedure allows placement
of e-PTFE sutures as replacement neochordae on a beating heart with-
out the need for cardiopulmonary bypass (CPB), while using 2D- and 3D-
transesophageal echocardiography (TEE) guidance [97, 21]. Two concen-
tric, round purse-string sutures with opposite closure points are placed using
large custom-made, rectangular Teflon pledgets and 2-0 non-absorbable su-
ture. Once the device enters the LV cavity, the apical purse-strings are gently
tightened to minimize blood leakage and facilitate device insertion (Figure
15 (a)). The device is directed towards the mitral valve plane using 2D-TEE
guidance (X-plane with ME LAX and MC views) avoiding interference with
adjacent subvalvular structures.
Progression from the LV toward the MV is performed by advancing the
device into the thorax perpendicular to the dome of the posterior leaflet
and MV annular plane. Once the MV annular plane has been crossed, the
TEE imaging mode should be switched from 2D to full 3D imaging, using
a surgical or en face view of the mitral valve to demonstrate the tip of the
device and to visualize movement of the device tip towards the target mitral
leaflet segment. When an appropriate position has been achieved, the jaws of
the device are opened and the leaflet edge is gently grasped by withdrawing
the device slowly away from the left atrium. Once the leaflet capture is
confirmed, is insered the device needle through the leaflet segment and made
a loop of the suture through the leaflet (Figure 15 (b)). Once the suture
loop has been retrieved from the device, the apical purse string sutures are
loosened and the device is retracted from the ventricle with the jaws open
and immediately after the two ends of the suture will be visualized and placed
through the suture loop to form a girth hitch knot, which is advanced to the
free edge of the captured leaflet while the two ends remain outside the chest
for final fixation on the apex (Figure 15 (c)). The device is reloaded with a
new suture and the procedure is repeated until enough neochordae have been
implanted to achieve the desired level of valve competence and subsequent
reduction in regurgitation (Figure 15 (d)). When the desired number of
neochordae have been placed, the apical purse-strings are tied. A French-eye
needle is used to pass all the neochordae through a round pledget which is
fixed with a 4-0 Prolene suture over the ventriculotomy and tourniquets are
placed over each of the neochordae. The respective length of each NeoChord
is then adjusted to achieve optimal leaflet apposition with the lowest degree
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Figure 15: NeoChord procedure: (a) posterolateral LV access, (b) leaflet capture, insertion
of the needle and loop of the suture through the leaflet, (c) performing of the girth hitch
knot, (d) loop of the procedure with a new suture until a reduction in regurgitation [22].
of mitral regurgitation. Once the length of the neochordae is adjusted, each
NeoChord is securely tied to the epicardial pledget.
5.3. MitraClip
A different solution useful for critical mitral regurgitation conditions and
for patients that cannot undergo conventional open-heart surgery has been
recently introduced. It consists of a “clip” (similar to a paper clip) introduced
trans-catheter that sticks together the two leaflet thus transforming the wide
prolapsed orifice in two small orifices, as shown in figure 16, that do not
allow regurgitation when closed. This method is a trans-catheter version of
a conservative surgical strategy called edge-to-edge repair [3]. After Mitral
clip, regurgitations is normally reduced or eliminated.
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Figure 16: Mitral valve edge-to-edge repair with Mitral clip.
6. Cardiac fluid dynamics
Cardiac fluid dynamics is characterized by formation of vortices inside the
heart chambers that interact with the surrounding tissues. The previously
discussed electro-mechanical cycle is associated with the dynamics of blood
flowing through the LV from mitral to aortic valve. The fluid dynamics inside
the left ventricle is a very intense dynamical phenomenon and represents a
fundamental element in cardiac function. The jet develops impulsively and
within a few hundreds of second reaches speeds above the meter per second
to enter a few centimeters long cavity. Then, the flow must reverse rapidly
the direction of motion of 180◦ to re-direct toward the aorta where it will exit
at the same high speed. The diastolic jet presents boundary layer separation
from the tips of the mitral valve and immediately gives rise to a swirling
motion within the cavity, as exemplified in figure 17.
The mitral orifice is slightly offset with respect to the ideal ventricular
axis for which the jet redirects towards the lateral wall and gives rise to an
asymmetrical swirling structure. The phenomenon is that of the formation
of a vortex ring, both during the A-wave and during the E-wave, that then
dissipates and stretched toward the outflow tract at the beginning of systole.
The length of the jet, the development and dynamics of the vortex struc-
ture and the phenomena associated with its impact on the endocardial tissue
depend on various physiological and pato-physiological factors. All these
elements can make the difference that makes the vortex a stable structure
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Figure 17: Numerical simulations during diastolic filling: (a) 2D vorticity formation, (b)
3D vorticity structure.
maintaining kinetic energy or an unstable structure that creates turbulence.
All myocardial regions must work in harmonic synergy to push blood (con-
sidered as an incompressible medium) toward the aortic exit and for receive
blood evenly, this because an incorrect timing of contraction or relaxation in
one region of the wall it makes that the blood is pushed toward the other
region, thus creating intraventricular pressure gradients that are not appro-
priate to create blood motion. Blood motion in the left atrium is driven by
the pulmonary veins that enter the atrium transversally and when the mitral
valve opens this possibly rotary motion flows down into the left ventricle in a
funnel-like patters. To date there are only few inforations of right ventricular
(RV) fluid dynamics, although RV function has been shown to be a major
determinant of clinical outcome in numerous cardiac dysfunction. This few
informations explain how the evaluation of RV geometry and blood motion is
extremely challenging because of the anatomic and functional complexities of
this chamber, which is difficult to visualize by two-dimensional imaging. The
flow inside the RV is expected to form a complex three-dimensional (3D) vor-
tex formation from the tricuspid valve as well as redirection of the jet towards
the lateral pulmonary outflow; because the circulation system is a closed one,
the volume of blood ejected from the RV must be equal to that ejected by
the LV. During diastole, a vortex ring develops past the tricuspid valve and,
given the transversal shape of the RV, one side of the vortex ring is close to
the interventricular septum where it rapidly dissipates. During systole, the
remaining portion of the vortex ring gets stretched toward the converging
pulmonary outflow giving rise to a highly swirling outflow that may promote
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proper mixing of the blood in the RV, thus prevents blood stagnation. The
fluid dynamics inside the LV has a two fundamental aspects, the kinematic
and the dynamic aspect.
6.1. Kinematic aspects
6.1.1. Flow transit analysis
The analysis of flow transit allows evaluating the properties of the washout
and/or stagnation inside the LV chamber and to identify the origin of the re-
gurgitant blood [24]. This analysis is performed here by solving a transport-
diffusion equation for a passive scalar. Call C(x,t) the concentration of a
passive marker of particles, the diffusion-transport equation is
∂C
∂t
+ ν · ∇C = D∇2C; (3)
that can be solved in parallel to the Navier-Stokes equation starting from the
initial condition C(x,0)=1, in this way the individual blood particles present
in the LV at end-systole are marked. The time evolution of C allows to
verify the washout of the LV and if the blood ejected or regurgitated is made
of blood that was previously present in the LV (marked by C=1 ) or that
just arrived from the atrium (C=0). In order to create a link with existing
literature in 4D Flow MRI, we compute the LV wash-out in terms of the
residual volume [39], this is defined by the blood volume that was present in
the LV before diastole and that is not expelled during systole. The residual
volume, normalized with the end-systolic volume (ESV), can be evaluated as
Vresidual =
1
ESV
∫
ESV
CdV. (4)
The increase of residual volume corresponds to an increased possibility of
blood aggregation.
6.2. Dynamic aspects
6.2.1. Hemodynamic forces
Hemodynamic forces are the forces that acting on blood to produce ac-
celeration and depend on the details of intraventricular flow [82]. The global
hemodynamic force vector was evaluated by computing the integral balance
of momentum
F(t) =
∫
V (t)
ρ
(
∂v
∂t
+ v · ∇v
)
dV, (5)
where V(t) indicates the 3D LV flow domain and the integral is computed
as the sum of values on each slice multiplied by the slice thickness; v(x,t)
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is the velocity vector field and ρ is the blood density [6]. The two terms in-
side the integral (5) represent the inertial and convective terms, respectively.
They can be rewritten expressing the second term as momentum flux at the
boundaries
F(t) =
∫
V (t)
ρ
∂v
∂t
dV +
∫
S(t)
ρv (v · n) dS = I (t) +M (t), (6)
where S(t) is the boundary surface of the fluid domain, V(t), and n is the
outward unit normal vector. The two terms are synthetically indicated by
the symbols I (t) and M (t). Consider Cartesian coordinates with the z-axis
directed from the LV apex (set at z = 0) to the center of the LV basal surface,
the x-axis directed from the center of aortic outflow to that of the mitral
orifice, the z-coordinate ranges from 0 to the LV height H(t) and A(z,t)
indicates the transversal LV area at each level z such that the ventricular
volume is
V (t) =
∫ H(t)
0
V (z, t)dz. (7)
The inertial term on the right hand side of (6) can be computed exactly as
I (t) = ρV (t)
dU(t)
dt
; (8)
where U (t) is the velocity vector averaged in the entire LV cavity whose
estimation allows one for I (t). For the z-component, at each level z, the
balance of mass is
d
dz
(Vz(z, t)A(z,t)) = −dA(z, t)
dt
, (9)
where Vz(z, t) is the average velocity at level z. Eq. (9) can be immediately
integrated to provide the z-component of the LV-averaged velocity to be
inserted in (8)
Uz(t) =
1
Vt
∫ H(t)
0
{∫ z
0
−dA(s, t)
dt
ds
}
dz. (10)
The x-component of the LV averaged velocity is due to the transfer of mo-
mentum along x from the mitral inflow to the outflow tract. The average
longitudinal velocity, Vz(z, t), that appears in (9) is associated to a purely
radial velocity on the transversal plane,
Vr(t) = −r
2
dVz
dz
, (11)
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that has no average component along x. The inflow/outflow fluid velocity is
predominantly oriented along the z-direction and approximately symmetric
with respect to the xz-plane, then the vertical velocity is expressed as the sum
of its mean value Vz(z, t) and an asymmetric component V
(1)
z (z, ϑ, t) such
that vz(x, y, z, t) ≈ Vz(z, t) + V (1)z (z, ϑ, t), where ϑ is the circumferential
coordinate, defined by x = r cosϑ, y = r sinϑ with r =
√
x2 + y2 and
therefore V
(1)
z (z, ϑ, t)=V
(1)
z (z, t)cosϑ, using the function cosϑ as asymmetry-
weighting function.
The conservation of mass can be recast in terms of asymmetric components
only
∂V
(1)
x
∂x
+
∂V
(1)
y
∂y
= −∂V
(1)
z
∂z
cosϑ; (12)
where the superscript (1) is used to indicate all components associated with
the nonsymmetric velocity V
(1)
z . The simplest in-plane velocity field that
satisfies (12) is
V (1)x (r, ϑ z) =
(
2
3
R− 1
2
r − 1
6
r cos 2ϑ)
)
dv
(1)
z
dz
;
V (1)y (r, ϑ z) = −
r
6
sin 2ϑ
dv
(1)
z
dz
.
(13)
The solution (13) included the integration constant to have zero radial ve-
locity at the boundary, assumed approximately circular of radius R(z, t) =
3
2A
∫
A
rdA, and its integration over the cross-section and along the LV axis
allows estimating the x-component of the velocity averaged in the LV
Ux(z, t) =
1
3V (t)
∫ H(t)
0
A(z, t)R(z, t)
dv
(1)
z
dz
dz
+
1
V (t)
∫ H(t)
0
Vxw(z, t)A(z, t)dz;
(14)
the last term in (14) was added to account for the possible net translation of
the LV boundary where Vw(z, t) is the average velocity of the LV boundary
at level z. Formula (14) requires the evaluation of the term dv
(1)
z
dz
. Assume
the simplest case of a linear decrease of the flux, from the basal profile to the
null value at the apex, writing a relation formally analogous to (9)
d
dz
(v(1)z A(z, t)) =
v
(1)
z (H)A(H)
(H)(t)
, (15)
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from which
dv
(1)
z
dz
(t) = v(1)z (H, t)
A(H, t)
H(t)
d
dz
(
z
A(z, t)
)
=
v
(1)
z (H, t)
H(t)
A(H, t)
A(z, t)
(
1− z
A(z, t)
dA
dz
)
,
(16)
Equation (16) into (14) gives the estimate of the x-component of the velocity
averaged in the LV
Ux(t) =
1
3V (t)
v(1)z (H)
A(H)
H(t)
∫ H(t)
0
R(z, t)
(
1− z
A(z, t)
dA
dz
)
dz +
1
V (t)
×
∫ H(t)
0
Vxw(z, t)A(z, t)dz.
(17)
This equation requires only the knowledge of the asymmetric velocity at the
basal level, z = H, at every instant. Both the average velocity Vz and the
asymmetric component V
(1)
z at the LV base can be obtained by measurements
of inflow and outflow. For completeness, we consider the y-component Uy(t),
which is only due to the transversal motion of the wall
Uy(t) =
1
V (t)
∫ H(t)
0
Vyw(z, t)A(z, t)dz. (18)
The convective term M (t) in (6) is evaluated from the knowledge of the
velocity distribution on the lateral wall surface, Slat , and on the basal sur-
face.The normal vector n is computed from the instantaneous surface geom-
etry to give the flux of momentum on the lateral wall. On the valvular plane,
assumed in first approximation with normal n = [0 0 1], the z-component of
the velocity is approximated by
vz(x, y,H, t) ≈ Vz(H, t) + v(1)z (H, t)cosϑ. (19)
In the same approximation, the x-component of the velocity is given by (11)
and (13)
vz(x, y,H, t) ≈ −r
2
dVz
dz
cosϑ+
(
2
3
R− 1
2
r − 1
6
r cos 2ϑ)
)
dv
(1)
z
dz
+ VΓ(t), (20)
where the last term is included to account for the circulation given by the
diastolic vortex formation in the LV; this term is zero on average but is
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normally present at the base. Eq. (20) can be recast using (9) and (18) as
vx(x, y,H, t) ≈ r
2
1
A
(
Vz
dA
dz
+
dA
dt
)
cosϑ+
1
A
(
2R
3
− 1
2
r − 1
6
r cos 2ϑ)
)
(
A
H
− dA
dz
)
v(1)z +
Γ(t)
2R
(21)
where Γ(t) is the vortex circulation. The circulation obeys the vortex for-
mation process due to the roll-up of the mitral shear layer, of intensity 2v
(1)
z ,
and a linear decay process,
dΓ
dt
=
{
2v
(1)2
z − Γτ , dV (t)dt > 0
0, dV (t)
dt
< 0
; (22)
where the dissipation decay time is taken τ = 0.1T to ensure a complete
vortex dissipation within less than one third of the heartbeat in normal sub-
jects as commonly observed. Performing the integral in (6) involving (19)
and (21) provides the following
M(t) = ρ
∫
Slat
vvndS+ρ
Vzv
(1)
z
R
3
(
A
H
− 1
2
dA
dz
)
+ R
6
dA
dt
v
(1)
z + VzVxwA+ VzΓ(t)
A
4R
VzVywA(
V
(1)
z + 12v
(1)2
z
)
A.
 ;
(23)
where the first term on the right hand side is the flux of momentum on the
lateral wall and the second terms represent that through the base with all
quantities.
6.2.2. Intraventricular pressure gradients
The intraventricular pressure gradient field (IVPG), ∇p, plays an funda-
mental role in LV function [85]. The ∇p field is the dynamic counterpart of
the intraventricular velocity field, v(x,t). The Navier–Stokes equation can be
rearranged as
∇p = −ρ
(
∂v
∂t
+ v · ∇v
)
+ µ∇2v , (24)
this equation is essentially equivalent to (5) and differs only for the viscous
friction (last term) that is usually nearly negligible along the short intra-
chamber paths. IVPG is therefore essentially made of the sum of the inertial
(local) acceleration and the convective term.
It is sometime suggested to directly compute the relative pressure field p by
solving the Poisson’s equation
∇2p = −ρ∇ · (v · ∇v) . (25)
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obtained by taking the divergence of (24), although care must be taken in
imposing appropriate boundary conditions [19, 33, 47] because (25) is sec-
ond order and the average pressure gradient (tri-linear terms in pressure) is
solution of the homogeneous Laplace operator and its value follows from the
boundary conditions only.
Figure 18: Relationship between relative pressure field and flow acceleration, shown by
the direction of the arrows, during: (a) Early diastole, (b) Late diastole, (c) Early systole.
Each picture shows the color-map of the pressure as by the color scale on the right (notice
the natural scale for kinematic pressure is cm2=T , T is the heartbeat; 200 units correspond
approximately to 20Pa or 0:15mmHg).
IVPGs drive blood motion during both ventricular ejection and ventric-
ular filling as shown in figure 18. They represent the ultimate result of LV
deformation and play a central role in cardiac function that governs blood
flow. Moreover, flow-mediated forces influence and participate to cardiac
adaptation in presence of pathologies.
The usage of hemodynamic forces has been recently renewed with the intro-
duction of methods able to estimate them non-invasively by medical imaging
and with much promising results as described in this recent publications[27,
28].
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7. Computational model
7.1. Geometric descriptions
The LV is a closed cavity bounded by the lateral LV wall and by the basal
surface that contains the mitral and aortic orifices representing the flow inlet
and outlet, respectively. The geometry of the lateral LV wall can be ob-
tained from several imaging technologies like CT, MRI or Echocardiography.
Different modalities differ for the time and spatial resolution, for providing
multi-slice or full 3D acquisitions, and for the availability in the clinical en-
vironment. Different software solutions are usually available in the different
modalities that help to identify the LV internal surface by user-assisted inter-
active procedures. Whatever the technology, the typical results is a dynamic
cast of the moving LV cavity that we eventually described by the positions
vector X(ϑ, s, t), where the structured parametric coordinates, (ϑ, s), run
along the circumference and from base to apex, respectively, t is time. The
usage of structured coordinates here was preferred for easier manipulation;
however, unstructured (e.g. triangular) descriptions could be equally used.
The position vector marks LV material points and their velocity is obtained
by time differentiation.
The MV geometry can also be extracted from the same imaging technolo-
gies relying on dedicated software tools for valvular delineation. Commonly,
the time resolution does not allow to reliably visualize and extract the MV
geometry other than in the fully-open (peak diastole) and fully-closed (dur-
ing early systole) configurations. The geometry of a normal MV, in closed
and open configurations, is shown in figure 19 as extracted from CT [108].
Whatever the imaging technology adopted, the 3D mesh of the leaflets’ sur-
face in the two configurations was reorganized in terms of an analogous set
of structured parametric coordinates, (ϑ, s), along the circumference and
extending from the annulus to the trailing edge. Additional reference mea-
surement must then be obtained for placing the extracted MV geometry
in the proper position relative to LV. This step is simplified when both LV
and MV geometries are extracted from the same image set such that they are
described with a common system of coordinates ensuring their automatic rel-
ative positioning. The most feasible imaging solution to this aim is given by
Trans-Esophageal 3D Echocardiography (3D TEE), that is commonly used
for visualization of valvular diseases, although image quality is not always
optimal. However, imaging technology is rapidly evolving and segmentation
options -that are out of the scope of this work- are continuously growing and
improving the feasibility of reliable geometric reconstructions.
When the valve shape is recorded at two instants corresponding to the
closed and the open configurations, say at ϕ = 0 and ϕ = pi/2, respectively,
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Figure 19: Normal mitral valve surface: (a) closed systolic configuration, (b) fully open
diastolic configuration; the color (red=anterior leaflet, blue=posterior leaflet) indicates
the local influence of individual opening angles in a model with two degrees of freedom.
where ϕ is the generic degree of local opening, the valve geometry at inter-
mediate positions must be reconstructed. This is performed here as follows,
at an intermediate degree of opening, ϕ, the position of the annulus (s = 0)
is evaluated by linear interpolation between the closed and open configura-
tions; then, starting from the annulus, the local metrics and the local normal
is estimated from linear interpolation and integrated along the radial direc-
tion s. This simple approach can be improved when the valve geometry or
other information is available at additional intermediate stages.
The MV geometry is eventually described as Xv(ϑ, s, ϕ), where ϕ is a
time-varying function that corresponds to the degree of opening. It is im-
portant to remark that at this stage there is not limitation on the number of
degrees of freedom allowed for valvular movement because, theoretically, the
degree of opening can be a function ϕ(ϑ, s, t). In the application presented in
§9, we first described the valve with one degree of freedom assuming ϕ(t) to
be a constant over the valvular surface, then we considered the two leaflets
moving independently with two degrees of freedom by modulating the func-
tion as
ϕ(ϑ, s, t) = ϕ2(t) + (ϕ1(t)− ϕ2(t))(1 + cosϑ)
2
, (26)
where ϕ1(t) is the opening angle of the long (anterior) leaflet and ϕ2(t) the
short (posterior) leaflet. The function (26) is displayed in figure 19 to show
the relative influence of the two leaflets in the valvular geometry.
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The aortic valve at the outlet is modeled by a simple open/close behavior
with no leaflets. The annulus of the MV and that of the aortic valve are then
connected to the annulus of the LV valve by an automatic linear connection
procedure to close the basal surface of the LV around the valves. The overall
geometry of the normal LV is shown in figure 20.
Figure 20: Complete geometry of ventricle, mitral valve (with open leaflets) and basal
surface including the open aortic orifice. Color is modulated with the vertical coordinate.
7.2. Fluid dynamics
The fluid dynamics is evaluated by numerical solution of the Navier-
Stokes and continuity equations
∂v
∂t
+ v · ∇v = −∇p+ ν∇2v , (27)
∇ · v = 0; (28)
where v(t,x) is the velocity vector field, p(t,x) is the kinematic pressure
field and ν is the kinematic viscosity (assumed 0.04cm2/s). Blood is inten-
tionally assumed as a Newtonian fluid. Indeed, blood is a mixture of elastic
corpuscular elements in an aqueous solution and either Newtonian or non-
Newtonian models are approximate. However, the influence of corpuscular
or non-Newtonian behavior is very small in the heart chambers [70] and it is
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negligible when compared with the limited accuracy of the clinical data used
as input.
The numerical solution is based on an immersed boundary method pre-
viously used in numerous studies [32, 31, 67, 68], which is briefly recalled
here. Equations are solved numerically in a rectangular domain using a
staggered, face-centered regular Cartesian grid where spatial derivatives are
approximated by second-order centered finite differences. Time advancement
is achieved using a fractional step method as follows. Velocity is preliminar-
ily advanced in time by the Navier-Stokes equation (27) using a low-storage,
third-order Runge-Kutta explicit scheme. This preliminary velocity, say vˆ ,
that does not satisfy the incompressibility constraint (28), is corrected by
adding a potential field δv = ∇q, such that v = vˆ + δv satisfies the con-
tinuity and the boundary conditions. The correction potential is found by
solution of the Poisson equation
∇2q = −∇ · vˆ ; (29)
and pressure is updated with q accordingly. Boundary conditions at the edge
of the computational box are set periodic in the x and y directions, while
they are zero pressure and normal velocity on the upper and lower ends along
z, respectively. The 2D Fourier decomposition permits fast solution of the
Poisson equation (29) as a sequence of tridiagonal systems for each harmonic.
Boundary conditions are also set on the moving immersed boundaries.
These comprise the LV lateral wall, the basal wall and the MV leaflets,
as defined above in §7.1. In addition, two cylindrical regions are added
extending from a region around the mitral valve (bounded by the LV edge
on the mitral side and the curve separating MV and aortic valve) and from
around the aortic valve to the upper edge of the computational domain;
these additional boundaries represent surrogates of atrium and aorta. They
are included for numerical convenience to avoid interference between the
outflow and the inflow outside the LV and to avoid nonphysical sharp corners
at the edge of the LV basal plane; the potential influence of these on the
intraventricular flow is evaluated in §8.1 dedicated to numerical verifications.
Following the IBM approach, the boundary conditions are imposed on the
intermediate velocity vˆ at the end of the Runge-Kutta time advancement
before imposing the correction obtained by (29) [30].
Given that the immersed boundaries do not coincide with the compu-
tational grid, a local interpolation scheme is commonly used to transfer
the precise boundary conditions at the surrounding computational points
[70, 71]. However, in clinical applications, the position of the LV bound-
aries is extracted by semi-visual assessments from images whose resolution
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is lower than the computational grid; therefore, the uncertainty regarding
the boundary position is commonly larger than the grid-size. Anatomically,
the LV endocardium presents small-scale elements that are not resolved in
imaging and are not reproduced in the extracted geometry. Finally, living ge-
ometries present continuous physiological variations and any instantaneous
measurement must be considered within a range of its natural variability.
Thus, in the context of simulations based on images and finalized to clini-
cal applications, the time-consuming interpolation scheme can be cut down
by simply closing all the faces of the cell containing the immersed bound-
ary and setting a velocity equal to the average of the points falling in that
cell. A computational step that can be performed with extreme efficiency.
Additionally, when computing the Navier-Stokes equation at the closed cells
corresponding to soft tissue, the cell viscosity is artificially increased to its
maximum stable value
νIB =
1
2∆t
(
1
∆x2
+
1
∆y2
+
1
∆z2
)−1
. (30)
This simplification avoids unrealistic sharp-edge boundaries, and improves
the numerical convergence by preventing from the creation of small scales
of sub-grid size. Physically, the spatial accuracy is still well above the un-
certainties and the variability of the boundaries that are somehow ”blurred”
about the closed cells. The influence of using the approximation (30) for a
hypothetically smooth boundary is analyzed in §8.2 below.
7.3. Valve dynamics
The LV geometry obtained from imaging expands and contracts during
the cardiac cycle and represents the driving force for blood motion. Differ-
ently, the dynamics of the mitral valve leaflets is driven by the interaction
with flow. We consider here a simplified model of interaction between flow
and MV that does not involve detailed tissue material properties. The valve
is assumed as a membrane that opens with the flow with few degrees of
freedom under the constraint of maintaining the shape consistent with that
extracted from images as described in §7.1. In general, the valve geometry
is described by its coordinates Xv(ϑ, s, ϕi) where the parameters ϕi(t), with
i = 1, 2 . . . N , represent the N degrees of freedom modulating valvular dy-
namics. The valve geometry is thus known once the value of each parameter
is known.
The statement that the valve opens with the flow translates mathemat-
ically in the congruence condition that the normal component of the valve
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velocity matches that of the fluid
v · n =
N∑
i=1
(
∂Xv
∂ϕi
· n
)
∂ϕi
∂t
; (31)
where n is the local normal to the valvular surface. Equation (31) applies
in general at every point of the continuous valvular surface. However, the
valve contains only a finite number N of degrees of freedom whose dynamics,
∂ϕi
∂t
, describes the constrained leaflets’ motion. In this case a solution in
weak form of (31) can be obtained by minimization of its square root error
integrated over the entire surface Av of the valve∫∫
Av
{
v · n −
N∑
i=1
(
∂Xv
∂ϕi
· n
)
∂ϕi
∂t
}2
dA = min. (32)
The least square minimization is recast in the form of a linear system
N∑
j=1
[∫∫
Av
(
∂Xv
∂ϕi
· n
)(
∂Xv
∂ϕj
· n
)
dA
]
∂ϕj
∂t
=
∫∫
Av
(v · n)
(
∂Xv
∂ϕi
· n
)
dA,
(33)
on the N unknowns ∂ϕi
∂t
, i = 1, 2 . . . N , that specify the motion of the valve
due to the blood flow starting from the initial closed configuration ϕi(0) = 0.
The matrix of the system (33)
Mij =
∫∫
Av
(
∂Xv
∂ϕi
· n
)(
∂Xv
∂ϕj
· n
)
dA, (34)
represents the mutual influence of the different degrees of freedom, it is a
diagonally-dominant and symmetric matrix and ensures that the system is
well conditioned. The model (33) was introduced here with reference to
the specific application for cardiac valves. Nevertheless, the mathematical
framework is rather general and not bounded to this application. It works
with an arbitrary geometry, here called Xv, whose possible configurations
are described by a finite number of degrees of freedom each one quantified
by the corresponding parameter, that in this case are the ϕi’s. These degrees
of freedom may represent spatially distinct elements, as it is in this case, or
they could represent parameters of a spectral representation or even mixed
descriptions. In the limit of N → ∞ this model represents a totally loose
surface where all points moves as if they were independent particles. When N
is small, this approach to valve dynamics represents a modal decomposition
where the overall motion is simplified in a few modes (degrees of freedom). It
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must be emphasized that the model (33) represents a drastic simplification
with respect to a complete FSI approach because the equations governing
the deformation of the tissue are not explicitly included. Thus this model
neglects the forces due to elastic recall and reproduces the asymptotic be-
havior where the valve moves with the flow with no elastic resistance other
than the constraint of moving in the prescribed set of geometrical configu-
rations deducted from images, as shown in figure 21, and that agrees with
that obtained from the clinical images. The approximation of this model
with respect to a FSI is paid back by the advantage of allowing simulations
solving a simple linear system and without requiring a detailed definition of
tissue properties that cannot be measured in vivo.
Figure 21: Geometry of a healthy MV for different degrees of opening of the two indepen-
dent leaflets. (a) ϕ1=0,ϕ2=0; (b) ϕ1=pi/6,ϕ2=0; (c) ϕ1=pi/3,ϕ2=0; (d) ϕ1=pi/2,ϕ2=0;
(e) ϕ1=0,ϕ2=pi/6; (f) ϕ1=pi/6,ϕ2=pi/6 ; (g) ϕ1=pi/3,ϕ2=pi/6; (h) ϕ1=pi/2,ϕ2=pi/6;
(i) ϕ1=0,ϕ2=pi/3; (j) ϕ1=pi/6,ϕ2=pi/3; (k) ϕ1=pi/3,ϕ2=pi/3; (l) ϕ1=pi/2,ϕ2=pi/3; (m)
ϕ1=0,ϕ2=pi/2; (n) ϕ1=pi/6,ϕ2=pi/2; (o) ϕ1=pi/3,ϕ2=pi/2; (p) ϕ1=pi/2,ϕ2=pi/2.
The dynamics described by the system (33) represents the asymptotic
limit of the loosest MV within the prescribed set of geometric configurations.
As such it can also represent a reference ground for the introduction of addi-
tional factors accounting for elastic resistance based on clinical observables.
These could depend on the elastic deformation through global coefficients as-
sociated to each individual degree of freedom, similarly to what introduced
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in [17] for a former model limited to one degree of freedom. The additional
coefficients could then be calibrated to additional measurements when these
are available.
The system (33), that gives ∂ϕi
∂t
, is evaluated in parallel to the Navier-
Stokes equation (27), that gives ∂v
∂t
during the Runge-Kutta time advance-
ment of fluid velocity and valve motion. At every time step, the fluid bound-
ary conditions are imposed at all immersed boundaries including every point
of the valve position based on the instantaneously computed valve motion,
this feedback completes the interaction between tissue and blood flow.
Finally, the aortic valve, which is downstream of the LV flow field, is
modeled as a simple orifice with a flat surface that is either open or closed.
Aorta is considered open when the mitral valve is closed and the normal
velocity, averaged over the position of the aortic valve surface, prior to setting
the boundary conditions, is directed outwards. This way, it is not necessary to
prescribe the open or closed state of the aortic valve by global considerations
because the exact instants of start-end of systole and diastole can be difficult
to define accurately in pathological conditions.
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8. Verifications
8.1. Numerical verification
The overall numerical implementation was extensively validated in previ-
ous studies. However, simulations of coupled problems involving both fluid
and solid elements are often challenging and results can be dependent on
space and time resolution even when the convective and diffusive stability
criteria are fulfilled. Therefore, we preliminarily performed an extensive val-
idation of the numerical method to verify the sensitivity of results to specific
numerical choices. To this aim we considered a single degree of freedom
valve model and a simple LV geometry used in a previous study [31]. We
show here the results for a same system simulated with a basic grid made of
128× 128× 160 points and 2048 time steps in one heartbeat, a refined grid
192 × 192 × 240 points and 3072 time steps, and the same eliminating the
model for atrium and aorta thus allowing inflow/outflow to communicate
in the space surrounding the LV. The coarser parameters were previously
demonstrated to ensure convergence of flow solution with valves modeled as
orifices without moving leaflets [32, 67, 68]. We monitored here the MV open-
ing angle, that represents the result of the interaction between flow and solid
elements, for which minor instantaneous differences can trigger progressively
increasing discrepancies.
Figure 22: Time course of the valve opening angle in three cases with different resolution
and removing the model of atrium and aorta upstream and downstream of the valvular
plane, respectively. The continuous line represents basic grid made of 128 × 128 × 160
points; the dashed line represents a refined grid 192 × 192 × 240 points; and the dashed
point line represents the same, only eliminating the model for atrium and aorta. The
shaded gray area represents the volume rate for reference (not to scale).
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The results of leaflet dynamics, reported in figure 22, are very similar
within this range of spatial and temporal resolution and are not influenced
by the presence of atrium/aorta models, which only reduces phenomena of
vortex interaction outside the LV. These results demonstrate the robustness
of the coupled computational model, possibly because it is based on integral
balances. The flow fields are essentially identical in the three cases.
8.2. Effect of immersed boundary viscosity
The IBM method for flow simulation presented in §7.2 proposes to use
an amplification of the viscosity coefficient, equation (30) when the fluid
equations are evaluated in correspondence of the immersed solid elements.
The appropriateness of such a method was suggested when the uncertainty
in the boundary position is larger than the grid size because the method
spreads the boundary condition over the computational cell.
We perform here a comparative analysis between numerical solutions ob-
tained with and without the introduction of equation (30) to verify the in-
fluence of this assumption with respect to considering a smooth boundary.
The comparison is carried out in the case of a normal LV (details about this
case are described below in §9).
Results show that the flow is largely unaffected by the introduction of this
artificial boundary viscosity, with the only difference limited to the presence
of very small scales that are sometime smoothed out; as an example, figure 32
shows the flow fields at the peak of the E-wave in the two cases. The compar-
ative analysis provides some support that this approach does not introduce
non-physical phenomena other than smearing out grid-size fluctuations near
the boundaries, a phenomenon that is meaningful when the position of the
boundary is not known with accuracy.
In particular, it can be useful in presence of sharp boundaries that are a
result of segmentation algorithms and whose details may not be physically
realistic. In such case, the immersed boundary approach can give rise to
similarly unrealistic small scales in fluid flow. To better describe this point,
figure 23 shows three insets with the enlargement of the vorticity field near
sharp boundaries computed with and without artificial viscosity at the solid
cells. The zero thickness boundaries sometime produces fluctuations of length
equal to the grid size that are a consequence of the jump across the solid cell.
Such fluctuations are significantly reduced when the viscosity is enhanced
at boundary cells. It must also be reminded that this artificial viscosity
is applied only to those computational cells that contain the solid elements.
Such cells are treated as fluid cells during the IBM solution and the flow equa-
tion are solved therein during the intermediate time-advancement steps when
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Figure 23: Details of the flow fields in a normal LV at peak E-wave computed (a) with
regular viscosity, (b) with the enhanced viscosity at the immersed boundary using identical
numerical parameters. Each picture shows the color-map of the normal vorticity (red to
blue from -200 to 200, units equal to the inverse of the heartbeat period) and the velocity
vectors (every 4 grid points) on a longitudinal plane crossing the center of MV, of aorta
and LV apex. The three panels report enlarged views of specific regions next to edges of
the immersed boundary.
discontinuities can influence nearby fluid cells. The enhanced viscosity essen-
tially reduces this influence and has the main effect of spreading the presence
of the solid to the entire cell. At the same time, this approach can improve
the stability of the numerical solution in presence of sharp boundaries; there-
fore, it may reduce the need of smoothing procedures when preprocessing the
borders obtained from image segmentation tools.
Therefore, the usage of equation (30) appears appropriate when the def-
inition of the anatomical boundaries is available with a resolution that is
comparable to the grid size or when such boundaries are described with un-
physical sharp edges.
8.3. Comparison with a FSI solution
The computational model is preliminarily evaluated in an idealized geom-
etry where a FSI solution is available from a study in literature for a healthy
LV with a simplified natural MV made of two separate leaflets [70]. The LV
presents a volumetric reduction of 60% with respect to its maximum size.
This corresponds to a peak Reynolds number Re =vpDa
ν
' 4200, where vp is
the maximum velocity averaged across the mitral annulus of diameter Da,
and a Strouhal number St = Da
vpT
' 2.9 × 10−2 and T is the heartbeat dura-
tion. It is worthwhile to remark that the peak velocity lasts lasts only for a
small fraction of the cycle and the average value of the Reynolds number is
about 660 and of Strouhal 0.18. The MV tissue properties are assumed in
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Figure 24: Flow fields in a normal LV at peak E-wave computed with (a) and without
(b) the enhanced viscosity at the immersed boundary. Each picture shows the color-map
of the normal vorticity (red to blue from -200 to 200, units equal to the inverse of the
heartbeat period) and the velocity vectors (every 4 grid points) on a longitudinal plane
crossing the center of MV, of aorta and LV apex; the three-dimensional gray surfaces
represents iso-surfaces of the λ2 parameter.
the FSI solution as those of an isotropic linearly-elastic membrane of uniform
(small) thickness, which includes mass and bending stiffness [29, 70]. For the
present comparison, mimicking the procedure proposed for application to
clinical data, the LV geometry coming from the FSI numerical solutions and
the MV geometry in the open and closed configurations are used as inputs
for the present model. The MV geometry is here described by 2 degrees of
freedom that exactly identify the individual leaflets.
It is important to remark that the two systems are not directly compa-
rable. The FSI simulation is obtained with a specific set of values for the
valvular tissue properties, whereas such elastic properties are not part of
the present asymptotic model where the leaflets motion is not subjected to
elastic resistance. Therefore, this comparative analysis aims to verify the
consistency of the asymptotic model and cannot purse to a one-to-one com-
parison as the physical systems are different.
Computations are performed starting from rest in both models and are
limited to the first diastole. Figure 25a-c shows the velocity fields obtained
by the FSI solution corresponding to three time instants (peak of the E-wave,
stasis between E and A waves, and peak of A-wave), and are compared with
those obtained at the same instants with the present model (figure 25d-f ).
Both models show similar gross features, with the entering jet displaced
towards the lateral wall (on the right side) in figure 25a,d, a weak downward
flow pattern about the valve leaflets in figure 25b,e, and a straight jet in figure
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Figure 25: Snapshots of the velocity field in the central transversal plane, y = 0, for
the idealized system introduced in [70]. Results from the FSI numerical study (a,b,c) and
from the present model (d,e,f ). The flow fields corresponds to peak E-wave (a,d), diastasis
(b,e), peak A-wave (c,f ); each picture reports the velocity vectors and the colormap of the
vertical velocity. (Due to different graphical representations, the color pattern in (d,e,f )
results smoother and cropped inside the valve.)
25c,f. The two numerical results differ mainly for the apparent different
degree of smoothness. This is partly imputable to the different numerical
techniques; moreover, in order to create the same graphical representation,
the present results were resampled from the staggered grid with (2x2 filtering)
and the flow field inside was cropped.
Some differences are also a consequence of differences in the valvular
dynamics. A first comparison of the motion of the anterior leaflet in the two
cases is reported in figure 27 using the same representation of the original
FSI reference [70]; the motion of the posterior leaflet, not reported here,
shows analogous behavior although with excursions that are about 20 times
smaller. The curves suggest that the present model corresponds to a system
with looser leaflets: the leaflet opens more rapidly during the E-wave, it
present a slightly larger closure during diastasis, and opens completely during
the E-wave when the elastic leaflets of the FSI model do not reach complete
opening.
Another quantitative comparisons is reported in figure 26 in terms of
metrics more directly related to valvular function like the projected opening
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Figure 26: Time evolution of the projected valve opening area (a), and of the mean cross-
valve vertical velocity (b): continuous line for the present asymptotic model, dashed line
for the elastic FSI model.
areaA(t), and the average cross-valve velocity v(t) (computed asQe/A, where
Qe is the effective volume rate across the valvular opening, as defined later
in equation (35). The comparison between the opening areas in figure 26
confirms that the present model corresponds to a looser valve that responds
more rapidly both during opening and closure.
Figure 27: Time evolution of the mean z-coordinate (a), and of the mean x-coordinate
(b) for the anterior leaflet: continuous line for the present asymptotic model, dashed line
for the elastic FSI model.
This difference does not affect significantly the value of fluid velocity,
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shown in figure 26; this is also due to the specific geometry of the leaflets
for this valve, visible in figure 25, that are extended in length with a large
lateral opening and a motion that is mainly transversal. The quicker opening
in the asymptotic model gives rise to a lower velocity during acceleration and
a peak flow that is reduced of about 6%, in this case, but that may become
more significant in other situations.
In summary, considering the existing difference between the two systems,
it was not expected that the asymptotic model results match very closely to
the FSI results. The comparative analysis shows that the present model cor-
responds to MV dynamics where the leaflets movements are more rapid with
respect to having elastic resistance with an overall congruence of the coupled
MV-LV fluid dynamics. These results provide a further partial support that
the model is compatible with the assumption of asymptotic behavior.
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9. Healthy and pathological LV with healthy MV
9.1. Fluid dynamics with healthy MV
The computational model is here applied to a normal healthy LV ex-
tracted from images as described in §7.1. The cardiac function is char-
acterized by an end-diastolic volume EDV = 113ml, end-systolic volume
ESV = 47ml, stroke volume SV = EDV − ESV = 67ml, and ejection
fraction EF = SV
EDV
= 59%. The specific volumetric curve, gives a velocity
at peak diastole of approximately vp ' 46cm/s averaged across the annulus
area (whose diameter is approximately Da ' 3.3cm). These figures corre-
spond to a peak Reynolds number Re =vpDa
ν
' 3800 and a Strouhal number
St = Da
vpT
' 7.2 × 10−2. However, the effective peak Re reaches about 1.7
times this value because the effective orifice area of the open mitral valve
is smaller that the annulus; although such high values are found for a very
limited period of time and the average Re during the entire diastole is about
940.
The flow field is shown in figure 28 at four instants during the cardiac
cycle. The overall intraventricular fluid dynamics is qualitatively analogous
to that previously described in literature with either orifice-like or different
models of the mitral valve in various different geometries of normal LVs
[85, 73, 100, 43]. During the early-filling an asymmetric vortex jet, whose
head is a deformed vortex ring, enters the LV. The vortex structure interacts
with the boundary layer of the lateral wall (right in the pictures) and partly
dissipates in diastasis leaving a weak clockwise circulation occupying most of
LV, while a second vortex ring follows during the atrial filling. It is worth to
note that this second ring is more regular because it is released by the rapid
closure of the MV mouth at the onset of systole, when a weak circulation
drives the flow toward the outflow tract.
The corresponding time course of the two leaflets opening angle is re-
ported in figure 29. The leaflets show a rapid opening during the accelera-
tion phase of the E-wave reaching the complete opening before the maximum
flow, which is in agreement with clinical observation. A small partial closure
occurs during the diastasis period, between the E and A waves. At the end
of diastole, closure starts at the deceleration phase of the A-wave, due to the
adverse pressure gradient, and quickly completes during the acceleration of
the systolic wave. The shorter, posterior leaflet is quicker in the early open-
ing and the final closure while the longer anterior leaflet follows shortly after
it. As a further check, the same picture reports the opening angle computed
by the MV model with one degree of freedom, which presents a comparable
valvular movement.
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Figure 28: Flow fields in the normal LV , computed with the two degrees of freedom
model, at four instants: (a) peak E-wave, (b) diastasis, (c) A-wave, (d) early systole;
as indicated in the volume curve inset. Each picture shows the color-map of the normal
vorticity (red to blue from -200 to 200 units equal to the inverse of the heartbeat period)
and the velocity vectors (every 4 grid points) on a longitudinal plane crossing the center of
MV, of aorta and LV apex; the three-dimensional gray surfaces represents one iso-surface
of the λ2 parameter.
Figure 29: Time course of the mitral valve opening angles in a normal LV. Continuous
lines are the anterior (black) and posterior (gray) leaflets opening angles in the 2 degrees
of freedom model; the dashed line is the result for a single degree of freedom model. The
shaded gray represents the volume rate for reference (not to scale).
In contrast, the pathological condition corresponds to a serious dilated
cardiomyopathy. The LV geometry is characterized by an enlarged end-
diastolic volume EDV = 199ml and end-systolic volume ESV = 142ml,
a reduced stroke volume SV = 57ml, and a depressed ejection fraction
EF = 29%. The flow field, computed by the two degrees of freedom MV
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model, is shown in figure 30 at four instants during the heart cycle. The
overall intraventricular fluid dynamics in dilated ventricles was previously de-
scribed in literature [68, 99] and it is confirmed in these results. All dynamic
phenomena are weaker because velocities are lower and a slow circulation
persists during large part of the heart cycle. The early diastolic jet enters in
a chamber with quasi-quiescent fluid, the ring propagates deeper in the large
LV, where vortex dissipation and rotating, stagnating fluid is found. The
formation of the second vortex ring during the A-wave brings an additional
small contribution to the deep circulation that persists during a large part
of the weak systole.
Figure 30: Flow fields in the the pathological, dilated LV, computed with the two degrees
of freedom model, at four instants: (a) peak E-wave, (b) diastasis, (c) A-wave, (d) early
systole; as indicated in the volume curve inset. Each picture shows the color-map of the
normal vorticity (red to blue from -200 to 200 units equal to the inverse of the heartbeat
period) and the velocity vectors (every 4 grid points) on a longitudinal plane crossing the
center of MV, of aorta and LV apex; the three-dimensional gray surfaces represents one
iso-surface of the λ2 parameter.
The time course of the MV leaflets, whose opening angles are reported in
figure 31, confirms the rapid opening at the acceleration of the E-wave and
the beginning of closure at the end of diastole with a rapidly completed at
the onset of the systolic wave. A remarkable difference from the healthy LV
is the significant partial closure during diastasis, which brings the posterior
leaflet to a temporary complete closure, and the incomplete opening during
the second diastolic wave. The comparison with the result of the one degree
of freedom model also corroborates the reliability of the approach.
9.2. Comparison with valveless mitral orifice
The intraventricular flow that develops in a normal LV in presence of the
MV is here compared with the flow obtained when the valve is replaced by a
circular orifice without leaflets, which is open in diastole and closed in systole
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Figure 31: Time course of the mitral valve opening angles in a pathological LV with
dilated cardiomyopathy. Continuous lines are the anterior leaflet (black) and posterior
(gray) opening angles in the 2 degrees of freedom model; the dashed line is the result for
a single degree of freedom model. The shaded gray area represents the volume rate for
reference (not to scale).
(so-called diode model). In the comparison we first consider an orifice at the
position of the annulus, whose effective area is larger than that of the actual
MV, then we consider an orifice with an area that is equal to the MV area
in the open configuration.
The flow fields are shown in figure 32 at the peak of the E-wave, one
instant that is directly influenced by the MV opening phase. The vortex ring
that develops from the larger orifice (figure 32b) is more regular, wider and
remains closer to the base with respect to that found with the MV model
(figure 32a). This result was expected because the circular orifice has a
regular trailing edge and the velocity of the fluid crossing the mitral orifice
is smaller. Interestingly, a similar result with a regular and basal vortex
ring is also found when the valveless orifice has the same size of the open
MV (figure 32c). Although the ring is stronger than before, it remains fairly
regular being shed from a planar circular orifice, moreover it remains closer
to the base despite the transvalvular fluid velocity is comparable to that in
the MV model. This is first imputable to the fact that the boundary layer
separation occurs from the LV base instead of the MV leaflets trailing edge
that lay downstream. Moreover, the ring is stretched and enlarged by the
background (initially irrotational) flow associated to the fixed orifice that
expands rapidly behind a circular sharp edge facing the flow. This behavior
is very different in presence of an opening valve that drives the flow in a
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Figure 32: Flow fields in a normal LV at peak E-wave computed with (a) and without
(b) the enhanced viscosity at the immersed boundary. Each picture shows the color-map
of the normal vorticity (red to blue from -200 to 200, units equal to the inverse of the
heartbeat period) and the velocity vectors (every 4 grid points) on a longitudinal plane
crossing the center of MV, of aorta and LV apex; the three-dimensional gray surfaces
represents iso-surfaces of the λ2 parameter.
funnel-like stream with velocities that are initially higher and are directed
downstream after the trailing edge.
9.3. Interpretation of MV dynamics
Physically, valvular opening is driven by the incoming transmitral flow
when the LV pressure falls below the pressure in the left atrium and pressure
difference is large enough for accelerating the entire fluid volume correspond-
ing to the filling flow rate dV
dt
. Valvular opening can thus be described with
the aid of conservation of mass [84].
Consider a control volume bounded by the surface within the mitral an-
nulus, the instantaneous valvular surface, and the orifice area inside the
trailing edge, Xe = Xv(ϑ, 1), the expression of mass balance states that the
total volume rate crossing the annulus is balanced by the volume allowed by
the displaced valve surface plus the flow Qe across the trailing edge orifice
dV
dt
=
∫∫
Av
v · ndA+Qe. (35)
When elastic resistance can be neglected, it can be hypothesized that the
valve opens with the flow without developing significant vortex shedding from
the trailing edge [81]. This means that an estimation of the velocity across
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the orifice does not differ significantly from that of the trailing edge ∂Xe
∂t
.
Within this assumption, the discharge Qe can be estimated by integrating
along a line, L, separating the anterior and posterior trailing edges, taking
the area between the facing edges and using the component normal to such
area of the mean velocity between them
Qe ∼=
∫
L
1
2
(
∂Xepost
∂t
+
∂Xeant
∂t
)
· n ∣∣Xepost −Xeant∣∣ dL. (36)
Equations (35), with Qe given by 36, provides a relationship between the LV
volumetric variation and valvular motion under the assumption of negligible
vortex shedding.
This relationship can be made more explicit when valve motion is de-
scribed by a single degree of freedom, ϕ(t). Using (31) with N = 1 to rewrite
the time derivatives, equation (35) can be rewritten
dV
dt
=
[∫∫
Av
∂X
∂ϕ
· ndA+ Qˆe
]
∂ϕ
∂t
; (37)
where
Qˆe ∼=
∫
L
1
2
(
∂Xepost
∂ϕ
+
∂Xeant
∂ϕ
)
· n ∣∣Xepost −Xeant∣∣ dL. (38)
For a given flow rate dV
dt
, equation (37) represents a first order ordinary
differential equation for the opening angle ϕ(t). It can be integrated with
initial condition ϕ(0) = 0, to provide an estimate of the initial phase of
valvular opening.
The valvular motion obtained by (37) is shown in figure 33 and compared
with that obtained from the numerical results for both the normal and the
pathological cases. The overall agreement is satisfactory for short times,
the difference increases as the valve approaches its maximum opening when
some shedding develops and the formula (36), or (38), becomes increasingly
approximated. Some discrepancy in the pathological LV is imputable to the
non-monotonic flow rate presenting a weak deceleration phase during early
diastole.
This result supports the interpretation that the asymptotic model in §7.3
corresponds to a valvular opening driven by the fluid crossing the MV without
resistance, such that the loose trailing edge moves in close accordance to the
fluid velocity and vortex shedding is initially negligible. In this case, valvular
opening is essentially a kinematic effect following mass conservation and it
does not depend on the geometric properties of the LV other than the flow
rate.
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Figure 33: Valvular opening at the onset of diastole as computed by the limiting model
(thick line) and obtained from the numerical simulation (think line). (a) normal and (b)
pathologic cases. The shaded gray are represents the volume rate for reference (not to
scale within the picture but equally scaled between (a) and (b)).
Analogous arguments can be applied to the description of the valvular clo-
sure at the transition between diastole and systole. Physically, MV closure
starts for the large adverse pressure gradient associated with the deceleration
of the late diastolic transmitral flow and continues rapidly during the accel-
eration of the backward directed systolic wave with no significant role played
by the vortices in the LV [65, 94]. Indeed, the vortex-induced velocities are
low (few cm/s) and the associated pressure are negligible with respect to the
intracardiac pressure differences at the onset of systole. In agreement with
the normal physiology, result show that MV closure completes during the be-
ginning of systole. This effect is associated to the phenomenon of false back
flow when the blood contained inside the MV cup returns into the atrium
when leaflets close. During this phase, a possible elastic recall may facilitate
valvular closure although this effect is expected to be small.
Differently, the ventricular vorticity might contribute to the partial valve
closure during the diastasis when transvalvular flow rate is small or absent
[94]. In this phase of the cardiac cycle, the vortex-induced rotational velocity
pattern inside the LV may creates a weak overpressure over the downstream
face of the leaflets (especially the longer anterior leaflet) and support partial
closure.
For further verification, we perform a numerical experiment and create
an artificial LV, which is characterized by the dilated geometry of the patho-
logical case but presents the volume rate identical to the normal case. This
artificial modified-dilated LV is obtained by starting with the enlarged end-
diastolic volume and modulating its original wall motion to ensure the nor-
mal volume rate. The modified-dilated geometry is thus characterized by the
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pathological end-diastolic volume EDV = 199ml and a normal stroke vol-
ume SV = 67ml, resulting to ESV = 132ml and pathological EF = 34%.
This model will be used here and in the following subsections to differenti-
ate the phenomena driven by the volume rate from those influenced by the
absolute volume size.
The flow field obtained with this modified-dilated model is shown in fig-
ure 34 at four instants corresponding to the same phase of the cardiac cycle
previously selected for the normal case. The overall intraventricular fluid
dynamics presents significant analogies to that found in the regular patho-
logical case with the diastolic vortex ring that propagates deeply in the LV.
A difference is the higher intensity of the MV jet and of the E- and A-wave
vortex ring developing a higher circulation in the chamber.
Figure 34: Flow fields in the modified-dilated LV , computed with the two degrees of
freedom model, at four instants: (a) peak E-wave, (b) diastasis, (c) A-wave, (d) early
systole; as indicated in the volume curve inset. Each picture shows the color-map of the
normal vorticity (red to blue from -200 to 200 units equal to the inverse of the heartbeat
period) and the velocity vectors (every 4 grid points) on a longitudinal plane crossing the
center of MV, of aorta and LV apex; the three-dimensional gray surfaces represents one
iso-surface of the λ2 parameter.
The evolution of corresponding valvular opening angles, ϕ1 and ϕ2, is
shown in figure 35. We want to underline here that the MV leaflets dynamics
during the initial opening phase is essentially identical to the one of the
normal case (shown in figure 29 and reported here with dashed lines for
comparison). This result confirms that the dynamics of valvular opening is
dominated by the early acceleration of the transmitral flow and does not
depend on the details of the downstream vessel geometry.
9.4. Mitral valve closure at the transition from diastole to systole
Analogous arguments can be applied to the description of the valvular
closure at the transition between diastole and systole. MV closure starts
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Figure 35: Time course of the mitral valve opening angles in the artificial modified-dilated.
Continuous lines are the anterior leaflet (black) and posterior (gray) opening angles in the
2 degrees of freedom model; the dashed lines are the corresponding angles in the normal
LV that has the same mitral volume rate. The shaded gray area represents the (normal)
volume rate for reference (not to scale).
for the adverse pressure gradient associated with the deceleration of the late
diastolic wave (A-wave) and continues rapidly during the acceleration of the
backward directed systolic wave.
This is confirmed by the same figure 35 that shows how the eventual final
phase of LV closure does not differ significantly between the normal and the
modified-dilated LV. This suggests that the physical mechanism is analogous
to that described above for the early opening. Although a precise model
cannot be easily developed for the absence of a reference starting time.
This observation supports the idea that closure is dominated by the ad-
verse pressure gradient at the end of diastole and the development of the
systolic flow, with no role played by the vortices in the LV [65, 94]. On the
other hand, the same picture 35 also shows that the early phase of closure at
the end of diastole, differs in the two cases indicating that the incipient clo-
sure can be influenced by LV flow rotation as repeatedly suggested [9, 101].
However, this influence is limited and will not likely affect, other than to a
negligible extent, the amount of back-flow into the atrium at the transition
from diastole to systole.
9.5. Partial MV closure at mid-diastole
The ventricular vorticity might contribute to the partial valve closure
during diastasis [94]. In this phase of the heart cycle, valvular motion cannot
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be driven by the valvular flow rate, that is small or absent, and pressure
gradients are equally small. Therefore, it is influenced by the small pressure
differences associated with the flow pattern that develops inside the LV.
In diastasis, the time profile of mitral dynamics displays remarkable dif-
ferences between the normal and the modified-dilated cases, despite the sim-
ilarities previously discussed for the opening and closure dynamics. In this
phase of the cardiac cycle, when the valvular flow is close to zero, the leaflets
in the normal LV undergo a limited partial closure (figure 29); differently,
those in the modified-dilated LV present a much larger partial closure that
persists for a longer period (figure 35). A large closure in diastasis was also
recorded in the pathological dilated ventricle (figure 31) corresponding to a
different, weaker profile of the flow rate.
The generalized reduced valvular opening at peak flow and enhanced clo-
sure during phases of low flow is a common clinical observation in dilated
LVs that was imputed to the weaker flow across the valve. These results sug-
gest that the phenomenon of partial MV closure during phases of low flow
is influenced by the dimension of the LV, with wider partial closures associ-
ated to larger LVs. Careful observations of the flow fields in the three cases,
partially visible in figures 28, 30 and 34, evidenced that the intraventricular
flow pattern in dilated LVs, either with pathologic or with normal flow rate,
presents the common structure made of vorticity located in the deep region
of the LV chamber. This differs from the normal case where flow circulation
involves the entire ventricle and the vorticity has a higher tendency to stay
in the anterior subvalvular region of the LV.
Figure 36 shows the distribution of pressure in the three cases during
diastasis; pressures are relative to the average LV value assumed as reference
zero (that is undefined in the numerical model). The pressure differences
are very small, over one order of magnitude smaller than the values found
during flow accelerations (that reach several thousands of the present units,
or a few mmHg), however these small pressure gradients represent the only
driving force in place. The normal case is characterized by a minimum of
pressure slightly downstream behind the valve, which corresponds to core of
the intraventricular vorticity pattern. This vortex structure represents the
wake behind the solid element, influencing its dynamics with a small lift force
helping to keep the leaflet open. Differently, in the large LVs, pressure reaches
its minimum values deep in the chamber, where the vorticity of the incoming
jet has accumulated and eventually dissipates. This pressure pattern does
not provide any lift to the leaflet and may rather enhance the development
of an adverse pressure gradient.
Therefore, in normal ventricles the confined natural circulation remains
near the valve producing a lift that sustains the leaflets opening. This effect
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is not present in enlarged ventricles when the vorticity travels to the apex
away from the valve. In this case the leaflets have a higher tendency to close
during diastasis and to anticipate closure at end diastole as shown in figure
35.
Figure 36: Relative pressure field during diastasis: (a) normal case, (b) pathological case,
(c) modified-dilated case; the exact instants are indicated by the volume curve insets.
Each picture shows the color-map of the pressure as by the color scale on the right (notice
the natural scale for kinematic pressure is cm2/T , T is the heartbeat; 200 units correspond
approximately to 20Pa or 0.15mmHg).
9.6. Slower deceleration of E-wave and mid-diastolic L-wave
The phenomenon of partial valvular closure described above may have an
impact on parameters commonly measured for diagnostic purposes. The flow
across the mitral valve is routinely measured in echocardiography by pulsed-
wave Doppler; this technique evaluates the time profile of the longitudinal
component of blood velocity averaged over a sample volume at the outlet
of the mitral valve leaflets. This time profile is then used to extract a few
indexes of diastolic function, like the ratio between the peaks of E- and A-
wave or the deceleration time (DT) of the E-wave [77]. Although the motion
of the mitral leaflet cannot be monitored directly, it directly influences the
velocity at the exit of the MV because it varies the size of the trailing edge
orifice.
A partial valvular closure during diastasis can give rise to a slower de-
crease of the velocity at the end of E-wave (longer DT), which is a first
indication of the so-called diastolic dysfunction. In particular, the devel-
opment of one additional peak of velocity between the E- and the A-wave,
commonly called L-wave, is considered an evidence of dysfunction [50, 60].
A dysfunction that is often associated with the dilatation of the LV (unless
it is accompanied with an alteration of the LV stiffness and hypertension).
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Figure 37: Time profile, during diastasis, of the downward component of blood velocity at
the outlet of the mitral valve. (a) pathological case, (b) normal case and modified-dilated
case (dashed line). The mean velocity across the annulus is reported with shaded gray for
comparison.
In our simulations the flow rate imposed by the volume change presents
a regular profile in the normal case and a small persistence of the E-wave
in the pathologic case. It is possible to include the influence of the leaflets’
motion and measure the mean velocity at the outlet of the MV to mimic
the clinical measurement of mitral flow. This is achieved by evaluating the
outflow discharge Qe(t) using equation (35), divided by the orifice area Ae(t)
Ae ∼=
∫
L
∣∣Xepost −Xeant∣∣ dL, (39)
and taking the downward directed component vMV (t) = −QeAenz, where nz is
the z-component of the average normal to the orifice surface of area Ae.
The mitral outlet velocity, reported in figure 37, shows evidence of the
delayed deceleration (longer DT) with appearance of a L-wave in the patho-
logical case. This observation, that does not occur in the normal case, also
appears in weaker form in the modified-dilated case in correspondence of a
normal flow rate.
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This result provides a physical explanation for observation commonly per-
formed in clinical cardiology. The larger DT due to a slower deceleration of
the diastolic E-wave and the possible emergence of mid-diastolic L-wave rep-
resent an increase of the velocity at the MV outlet during diastasis, which
can be partially imputable to the closure of the mitral leaflets. This demon-
strates how the MV dynamics may have a potential impact on the existing
clinical indicators representing an explanation or a confounding factor to be
considered for proper clinical validations.
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10. Healthy and pathological LV with prolapsed MV
10.1. MVP geometries
The analysis is performed on a series of MVs with different degrees and
types of prolapse. On the one end, a normal geometry (called healthy-1) is
used for reference, figure 38 (a). MVP in figure 38 (b) is a prolapse P3 of
type I MR with incomplete coaptation of the leaflet and insufficient surface
of coaptation of the leaflet and consequent reduction of the mitral valve area
MVA. The MVP in figure 38 (c) is a prolapse P2 of type II MR with leaflet
prolapsed caused by elongation of the chordae tendineae.
Figure 38: Closed and open configuration of (a) Healthy MV, (b) P3 Prolapse, (c) P2
Prolapse.
In addition, in order to evaluate intermediate conditions, we have arti-
ficially modified the dimension of the P3 prolapse by stretching the leaflets
to let facing edges approach each other. Figure 27 shows the MV geometry
at end-systole with original prolapse (P3, figure 39 (a), equal to figure 38
(b)), a reduction of 25% of the original prolapse (P3-25%, figure 39 (b)), of
50% (P3-50%, figure 39 (c)) and the 100% correction to non regurgitating
geometry (P3-Healthy, figure 39 (d)).
Numerical simulations are performed with six different MVs in both
healthy and pathological LVs, this allows to compile an initial general picture
of fluid dynamics properties associated to the evaluation of the regurgitation.
Table 1 summarizes the different conditions analyzed in the present study.
10.2. Regurgitation analysis
This section describes the methods used for the numerical calculation of
the MR properties. The effective area of the MV orifice area is computed by
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Figure 39: Original MV with P3 prolapse (a), modified MV with P3 prolapse reduced by
25% (b), reduced by 50% (c), reduced by 100% (d).
MV LV LV
Healthy Healthy Dilated
P3 Healthy Dilated
P2 Healthy Dilated
P3-25% Healthy Dilated
P3-50% Healthy Dilated
P3-Healthy Healthy Dilated
Table 1: List of numerical simulations with different MVs and LVs
measuring the space between the leaflets trailing edge
MVO(t) =
∫ L
0
∣∣Xeant −Xepost∣∣ dL; (40)
where Xe=Xv(ϑ, 1), is the trailing edge that is subdivided in the anterior
and posterior leaflets, and L is the length of a curve running along the mid-
point between the two edges. The EOA of a regurgitant orifice is the MVO
evaluated from equation (40) during systole when the MV is in the closed
configuration. The calculation of the blood flow rate effectively crossing the
MV orifice is computed by
QMV (t) =
∫ L
0
v rel · n
∣∣Xeant −Xepost∣∣ dL, (41)
where the relative velocity, v rel = v¯− ∂∂t
Xeant−Xepost
2
, is the difference between
the fluid velocity averaged along the line between the two facing edges and
the velocity of the edges themselves, and n is the local normal. From this,
the regurgitating blood volume is the flow crossing the MVO during systole
Vreg =
∫
sys
QMV (t)dt. (42)
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It will be useful, for comparison, also to compute the blood volume crossing
the MV annulus (MVa) to separate the contribution due to leaflets motion
QMV a(t) =
∫
AMV a
(vrelMV a · n) dA, (43)
where AMV a is the area of MVa, the relative velocity v relMV a = v¯MV a− ∂X¯MV a∂t
is the difference between the fluid velocity averaged over the MVa and the
average velocity of the annulus, where X¯MV a is the average position vector
of the MV annulus. Then, the regurgitating blood volume measured across
the MVa is
VregMV a =
∫
sys
QMV a(t)dt. (44)
For further reference, we have also considered the flow crossing the LV an-
nulus
QLV (t) =
∫
ALV a
(vrelLV a · n) dA, (45)
where ALV a is the area of LVa, the relative velocity v relLV a = v¯LV a − ∂X¯LV a∂t
is the difference between the fluid velocity averaged over the LVa and the
average velocity of the annulus, where X¯LV a is the average position vector of
the LV annulus. Then, the blood volume measured across the LVa is
VLV a =
∫
dia
QLV (t)dt. (46)
These same evaluations introduced above, can be extended to define the qual-
ity of blood present in these volumes. The knowledge of the concentration
field, computed by (3), allows recognizing the amount of flow that is com-
posed of blood that was present in the LV before the beginning of diastole
(hereafter indicated as old) or, by difference, that entered the LV during last
diastole (fresh). The old blood volume regurgitated by MV orifice is obtained
by extending (41) as
QMVold(t) =
∫ L
0
v rel · n
∣∣Xeant −Xepost∣∣C dL AMV a, (47)
where C is the concentration measured at the MV orifice; the corresponding
volume is
Vregold =
∫
sys
QMVold(t)dt. (48)
67
10.3. Fluid dynamics with MVP
In this section, we describe the fluid dynamics that develops in normal and
dilated LV geometry in presence of the different MV morphologies described
in §10.1. The normal LV is characterized by EDV = 113.47ml, ESV =
47.52ml, ESV = 66.95ml, and ejection-fraction EF = SV
EDV
= 59%.
Figure 40: Flow field in the normal LV in presence of a healthy MV (a,d), MV with
P3 Prolapse (b,e) and P2 Prolapse (c,f). Diastolic flow at peak E-wave (a), (b), (c); as
indicated in the volume curve inset (black line in (g)); the normal vorticity is shown by
red to blue color from -200 units to 200 units equal to the inverse of the heartbeat period
and the velocity vector (every 4 grid points) on a longitudinal plane crossing the center of
MV, of aorta and LV apex; the three-dimensional grey surfaces represents one iso-surface
of the λ2 parameter. The lower side is the three-dimensional flow field in the normal LV
calculated with the passive scalar iso-surface method at the same instants of early systole
at value C=0.4; as indicated in the volume curve inset. The inset (g) reports the volume
curve and the instant of the case analyzed.
The flow field in the normal LV at peak diastole is shown in figure 40
(a-c) in correspondence of (a) Healthy, (b) P3 and (c) P2 MVs. The flow
with healthy MV presents the typical asymmetric vortex ring that enters
into the LV, the P3 case shows a vortex ring that deviates and breaks down
when impacting the posterior wall, finally the mitral jet in the P2 MV is
characterized by an irregular flow that enters in depth in the center of the
LV probably because of the slightly reduced dimension of the MVO. Figure
40 (d,e,f) reports the corresponding concentration field at peak systole. The
healthy case evidences blood that is well mixed between old and fresh blood
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in the entire chamber; differently, the prolapse MVs are associated with a
greater presence of old blood near the apex and displays regurgitation in
atrium.
Figure 41: Flow balance in diastole. (a): comparison between diastolic dV/dt (dashed dark
line) and diastolic QLV (continuous grey line) in healthy LV. In systole, (b): comparison
of the QMVa (continuous line) and QMV (dashed line) respectively for healthy-1 MV (dark
line), P3 MVP (blue line), P2 MVP (red line) and the grey continuous line is the systolic
dV/dt, (c): Old blood flow regurgitated in atrium, computed by QMVold respectively for
healthy MV (dark line), P3 MVP (blue line), P2 MVP (red line) and the grey continuous
line is the systolic dV/dt.
The flow profile, dV/dt, for the healthy LV is shown in figure 41 (a)
during diastole and in figure 41 (b) during systole (light grey curves), their
integral represents the stroke volume 66.95cm3. For comparison, Figure 41
(a) also reports the time profile of QLV computed by equation (45), that
gives and integral VLV = 67.25cm
3. Such agreement between volume change
and measured flow rate represents an indirect agreement of the reliability of
the present IBM calculation.
The systolic outflow in aorta in figure 41 (b) is plotted together the blood
flow that crosses the LV annulus and returns to the atrium, QMV a computed
by (43) (continuous lines), and with the blood flow that crosses the MV ori-
fice, QMV computed by (41) (dashed lines), respectively for normal (healthy:
black color) and prolapsed MVs (P3: blue, and P2: red). The first part of
systole corresponds to the closing period of the MV, here the continuous and
dashed curves differ because QMV a includes the volume of blood contained
in the MV pool above the orifice that returns back to the atrium during MV
closure; afterwards the curves come together along a common path. The ini-
tial difference represents the so-called false regurgitation that identifies the
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physiological blood flow returning in the atrium during the closure of the MV
leaflets, which is estimated by the difference Vregfalse = VregMV a − Vreg com-
puted with (44) and (42). The same curves of regurgitating flow are shown
in figure 41 (c) limiting the calculation to the old blood only, computed by
equation (47). The overall entity or old blood regurgitations is nearly pro-
portional to the total regurgitations; nevertheless, it is evident that the old
blood enters the atrium mainly during the second half of systole when ejec-
tion has involved the entire LV volume. The initial regurgitation is mainly
composed of fresh blood that reached the region just behind the behind the
valve and is the first involved in the back flow.
The integral results relative to all the different MVs are reported in Ta-
ble 2. The healthy valve is a physiologic MV that presents a non-zero
EOA = 0.06cm2, corresponding to a tiny hole 1% the valve size that is
not caused by pathological valvular deformation, or imputable to minor in-
accuracy in image segmentation. Results show how the increase of the EOA
corresponds to an increase of Vreg, whose correlation will be analyzed later.
Regurgitation reaches about 10% of the SV in the present P3 prolapse and
about 20% in P2. It is noticed that a small non-zero regurgitation is also
found in healthy valves, indicating that MV velocity during closure is slightly
lower than blood velocity. The false regurgitation, Vregfalse = VregMV a − Vreg,
represents the fresh atrial blood that does not cross the MV orifice and re-
turns into the atrium at the beginning of systole. This does not depend on
the EOA and is more a consequence of the MV shape.
MVA
[cm2]
EOA
[cm2]
EOA
MVA
[%]
SV
[cm3]
VregMVa
[cm3]
Vregfalse
[cm3]
Vreg
[cm3]
Vreg
SV
[%]
Healthy 6.20 0.06 1 66.95 2.07 1.64 0.43 0.65
P3 4.83 0.52 11 66.95 8.87 2.58 6.29 9.40
P2 4.26 0.87 20 66.95 13.42 0.66 12.76 19.07
P3-25% 4.83 0.39 8 66.95 4.57 2.49 2.08 3.11
P3-50% 4.83 0.26 5 66.95 2.58 1.00 1.58 2.37
P3-Healthy 4.83 0 0 66.95 1.70 0.80 0.80 1.20
Table 2: Global results in healthy LV. MVA=Mitral Valve Area, EOA=Effective ori-
fice area in MV closed position, EOAMVA=EOA normalized with MVA, SV=Stroke Vol-
ume, VregMV a=Total Regurgitation, Vregfalse=False Regurgitation, Vreg=Regurgitation
from orifice,
Vreg
SV =V reg regnormalized with SV.
Table 3 shows the volume of residual old blood stagnant into the LV at
end systole and the volume of old blood regurgitated in atrium. These results
show that the residual volume Vresidual is only moderately influenced by the
MV regurgitation that, therefore, does not directly influence the LV wash-
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out. On the other hand, the increase of regurgitation is associated with a
larger percentage of old blood regurgitated that reaches a value as high as
50% in the most diseased case.
EOA
[cm2]
Vresidual
[%]
Vregold
[cm3]
Vregold
Vreg
[%]
Healthy 0.06 28.50 0.03 6.98
P3 0.52 26.07 2.36 37.52
P2 0.87 30.67 6.42 50.31
P3-25% 0.39 25.28 0.70 33.65
P3-50% 0.26 25.60 0.09 5.70
P3-Healthy 0 26.12 0.01 1.25
Table 3: Global transit results in healthy LV. EOA=Effective orifice area in MV closed
position, Vresidual is the LV residual volume at end-systole, V regold is the quantity of the
old blood regurgitated in atrium, V regoldV reg is the old blood regurgitated normalized with
V reg, Vresidual=Residual volume.
The same analysis is repeated in correspondence of a pathological ventric-
ular geometry corresponding to a severe dilated cardiomyopathy. The dilated
LV is characterized by an enlarged end-diastolic volume EDV = 199.31ml,
end-systolic volume ESV = 142.50ml, SV = 56.82ml, and ejection-fraction
EF = 29%.
The flow field in the dilated LV at peak diastole is shown in figure 42 (a-c)
in correspondence of (a) Healthy, (b) P3 and (c) P2 MVs. The overall in-
traventricular fluid dynamics in dilated ventricles was previously described
in literature [68, 99] and it is qualitatively confirmed by the present results.
All dynamic phenomena are weaker because velocities are lower, and a slow
circulation persists during a large part of the heart cycle. In the dilated LV
with healthy MV (figure 42 (a)) the early diastolic jet enters in a chamber
with quasi-quiescent fluid, the ring propagates deeper in the large LV before
it interacts with the walls and partly dissipates. In presence of pathological
MV (figure 42 (b, c)), the mitral jet and the vortex ring at the jet’s head
presents the same deviation previously noticed in the normal LV, which is
caused by the arrangement of the MVO. Figure 42 (d-f) reports the corre-
sponding concentration field at peak systole. Blood is well mixed between
old and fresh blood but with more marked presence of old blood in the entire
chamber caused by a larger size of the pathological ventricle and reduced
wash-out.
The flow profile, dV/dt, for the dilated LV is shown in figure 43 (a)
during diastole and in figure 43 (b) during systole (light grey curves), their
integral represents the stroke volume 56.82cm3. For comparison, Figure 43
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Figure 42: Flow field in the dilated LV in presence of a healthy MV (a,d), MV with
P3 Prolapse (b,e) and P2 Prolapse (c,f). Diastolic flow at peak E-wave (a), (b), (c); as
indicated in the volume curve inset (black line in (g)); the normal vorticity is shown by
red to blue color from -200 units to 200 units equal to the inverse of the heartbeat period
and the velocity vector (every 4 grid points) on a longitudinal plane crossing the center of
MV, of aorta and LV apex; the three-dimensional grey surfaces represents one iso-surface
of the λ2 parameter. The lower side is the three-dimensional flow field in the dilated LV
calculated with the passive scalar iso-surface method at the same instants of early systole
at value C=0.4; as indicated in the volume curve inset. The inset (g) reports the volume
curve and the instant of the case analyzed.
(a) reports the time profile of QLV computed by equation (45), that gives and
integral VLV = 56.82cm
3. The systolic outflow in Figure 43 (b) is computed
and reported with the same procedure described above for the normal LV,
and confirms the presence of false regurgitation at the beginning of systole.
Similarly, the quantity of old blood regurgitated, shown in figure 43 (c),
presents a trend that is similar to the normal case.
Quantitative evaluations are obtained by the integral results reported in
table 4 and table 5 (to be compared with previous tables 2 and 3 relative to
normal LV). The values of regurgitation are comparable between normal and
dilated conditions in correspondence of the save MV. This is true both in
absolute and relative terms, considering that the two LVs have a similar SV.
A remarkable difference is found in terms of wash-out, where the dilated LV
presents a much larger residual volume, independently from the MV. Also,
the quantity of old blood regurgitated is partially increased, indicating that
some larger amount of old blood returns back to the atrium and further re-
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Figure 43: Flow balance in diastole. (a): comparison between diastolic dV/dt (dashed dark
line) and diastolic QLV (continuous grey line) in dilated LV. In systole, (b): comparison
of the QMV a (continuous line) and QMV (dashed line) respectively for healthy-1 MV
(dark line), P3-3 MVP (blue line), P2 MVP (red line) and the grey continuous line is
the systolic dV/dt, (c): Old blood flow regurgitated in atrium, computed by QMVold
respectively for healthy-1 MV (dark line), P3-3 MVP (blue line), P2 MVP (red line) and
the grey continuous line is the systolic dV/dt.
duces the overall washout of the entire left heart thus theoretically increasing
the risk of platelet activation and thrombus formation.
MVA
[cm2]
EOA
[cm2]
EOA
MVA
[%]
SV
[cm3]
VregMVa
[cm3]
Vregfalse
[cm3]
Vreg
[cm3]
Vreg
SV
[%]
Healthy 6.20 0.06 1 56.82 2.41 2.40 0.10 0.18
P3 4.83 0.52 11 56.82 9.27 2.01 7.26 12.77
P2 4.26 0.87 20 56.82 11.74 0.04 11.70 20.60
P3-25% 4.83 0.39 8 56.82 5.78 1.96 3.82 6.73
P3-50% 4.83 0.26 5 56.82 3.53 2.05 1.48 2.61
P3-Healthy 4.83 0 0 56.82 3.02 2.01 1.01 1.77
Table 4: Global results in dilated LV. MVA=Mitral Valve Area, EOA=Effective ori-
fice area in MV closed position, EOAMVA=EOA normalized with MVA, SV=Stroke Vol-
ume, VregMV a=Total Regurgitation, Vregfalse=False Regurgitation, Vreg=Regurgitation
from orifice,
Vreg
SV =V reg normalized with SV.
Figure 44 (a) reports the correlation between the functional measure of
valvular insufficiency, given by the regurgitant volume, and the structural
measure, given by the EOA. Once these values are properly normalized the
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EOA
[cm2]
Vresidual
[%]
Vregold
[cm3]
Vregold
Vreg
[%]
Healthy 0.06 68.50 0.01 10
P3 0.52 69.79 3.74 51.51
P2 0.87 70.90 8.33 71.70
P3-25% 0.39 69.70 1.88 49.21
P3-50% 0.26 69.49 0.57 38.51
P3-Healthy 0 69.02 0.61 60.4
Table 5: Global transit results in dilated LV. EOA=Effective orifice area in MV closed
position, Vresidual is the LV residual volume at end-systole, V regold is the quantity of the
old blood regurgitated in atrium, V regoldV reg is the old blood regurgitated normalized with
V reg, Vresidual=Residual volume.
two quantities present a direct proportionality
V reg
SV
∼= EOA
MV A
. (49)
with good accuracy without evident differences for the different type of pro-
lapse or the LV size. Figure 44 (b) shows a good correlation between the total
regurgitation and the portion made of old blood; however, some difference is
noticeable between normal and dilated LVs as previously underlined.
Figure 44: Correlation between:
Vreg
SV and
EOA
MVA considering all MV cases and healthy
LV (square) and dilated LV (triangle) (a), Vreg and Vregold considering all MV cases and
healthy (square) and dilated LV (triangle) (b).
74
11. Discussion of model limitations
The computational model introduced here should not be confused with
a FSI model, primarily because it does include the elastic properties of the
tissues that would be required to solve the momentum equation for the solid
elements. Therefore, it describes an asymptotic behavior only and was de-
signed to provide a relatively straightforward application of LV flow simula-
tions in clinical conditions when the mechanical properties of tissue are not
available or cannot be extrapolated. To reach this objective, the model in-
cludes a number of simplifications that correspond to a series of limitations
that are briefly summarized here.
First of all, the set of possible valve configurations is given a-priori as a
function of few evolutionary parameters (degrees of freedom). Hence, there
is no guarantee that the effective deformation of the tissue elements belongs
to such a pre-defined set of configurations; the actual reliability depends
on the reliability and completeness of the information used to create such
configurations and to the associated degrees of freedom. Secondly, the fluid-
tissue interaction describing MV motion represents an asymptotic behavior
where the valve moves with the flow with no resistance given by an inter-
nal anatomic structure other than the constraint of moving inside the set
of predefined configurations. Therefore, the model corresponds to the loos-
est tissue dynamics within those geometric configurations. In perspective,
the system (33) may be integrated with elastic terms dependent on the de-
formation through global coefficients that could be calibrated to additional
measurements [17]. Finally, the model also neglects the influence of chor-
dae tendineae that ensure unidirectional flow by constraining the valve from
opening toward the atrium. In this regard, this study did not consider ad-
ditional effects imputable to the chordae, such as their tethering that may
influence MV dynamics in dilated LVs. It also neglects the possible impact
of leaflets with surrounding tissues, that are simply anticipated by limiting
the allowed configurations.
As discussed in the introduction, a complete FSI approach is the only
methodology for ensuring complete reproduction of the dynamics for both
fluid and solid phases [45, 70, 59, 63, 43, 109, 11]. On the other hand, the
development of FSI in living biological systems presents exceptional difficul-
ties in the definition of tissue properties, including constitutive equation and
elastic parameters which may be space-varying and non-isotropic [92, 18, 64],
that cannot be easily estimated in vivo. In general, in the perspective of a
clinical application, we are left with a dichotomy between simplified approxi-
mated models, that may agree with limited measurable information but may
not be generally valid, and complete FSI models based on an approximation
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of the effective set of tissue parameters that may not be realistic for the spe-
cific case under analysis. Aware of these limited options, the present model
follows the first route introducing a clinical imaging-based approach, with
the objective of providing one additional possible approach.
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12. Conclusion
This study presented a numerical approach to the LV fluid dynamics that
includes the interaction with MV leaflets. The method is designed for inte-
gration with medical imaging in compliance with the accuracy of information
effectively available in clinical applications. This model of valvular dynamics
corresponds to an asymptotic description of leaflet motion when information
about tissue properties are not available or cannot be extrapolated. It rep-
resents an improvement with respect to using valveless orifice and provides a
more realistic reproduction of the flow below the valve. This numerical study
provides some insights into the fluid dynamics of mitral valve regurgitations.
The calculation employed a simplified model of MV deformation, based on
clinical images, which was found to be appropriate for flow modeling pur-
poses. The analysis has been performed for different prolapsed MVs inserted
in both a normal and a dilated LV. First, the study evidenced the presence
of a false regurgitation made of blood that was in the MV cup and returned
the atrium during MV closure. In small prolapses, this false volume can
be comparable to the real regurgitation and should be considered in clinical
measurements. The amount of regurgitation is principally due to the effec-
tive insufficiency of the MV without a significant influence of the geometry of
the LV. The amount of regurgitating volume, expressed in percentage of the
stroke volume, is found to be an equivalent measure of the effective orifice
area, expressed in percentage of the MV area. The dimensions of the LV
enter into play in terms of the quality of the regurgitant blood; larger LVs
present a reduced wash-out that reflects in a larger percentage of old blood
returning to the atrium, thus increasing the risk of blood aggregation and
thrombus. This non-invasive method is useful for the assessment of blood
flow, to improve early detection of cardiac dysfunctions and for provide a
concrete helpful in clinical routines.
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